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 The present thesis` main objective was to examine time-trends related to CBT as an 
anti-depressive treatment. A meta-analytic approach was the tool for such investigations, in 
which the formats of individual, group (GCBT), and mindfulness-based cognitive behavioral 
therapy (MCBT) were explored from a temporal point of view, and the results subsequently 
summarized in four articles. The meta-analyses measured the development of effect sizes (ES) 
with time. Potential moderator variables were also investigated. The primary outcome 
measure was the BDI, while the HDRS was utilized as a secondary outcome measure.  
 The results revealed large ESs for all treatment formats, ranging from g = 0.80 to 1.89. 
A significant decline in treatment effects with time was observed across all statistical 
conditions for individual CBT, while GCBT showed a significant rise in ESs with the passing 
of time, based on the results from the primary outcome measure. For MCBT, there were 
found no trends related to the passing of time. Moderator analyses revealed that the fall in ES 
for CBT was more pronounced for trials where the original treatment manual had been 
utilized, while the rise in GCBT effect sizes was limited to trials were no specific treatment 
manual had been used (or reported).  
 The conclusion is that CBT is efficient in all formats when it comes to battling 
depression. However, the results also point to the importance of continuous updates or 
adaptations, in order to be in line with societal developments. This applies for treatment 
formats, manuals, and outcomes measures alike. Flexibility and frequent updating/adaptation 




Depressive disorders (DDs) can be highly disabling and are ranked third in terms of 
disease burden as defined by the World Health Organization (WHO, 2014), and first among 
all psychiatric disorders in terms of disability adjusted life years (Wittchen et al., 2011). In 
addition, DDs seem to be rising globally (Everyday Health, 2013), and a 20-percent annual 
increase in its incidence has been predicted (Healthline, 2012). Improvements in treatment 
methods and prevention measures, and the availability of community psychiatric services are, 
therefore, as important as ever before. In response, the WHO has prioritized the combating of 
depression by launching an action plan called “The Mental Health Gap Action Program,” 
aimed at improving mental health services globally (WHO, 2012).  
Psychotherapy is a critical asset for dealing with the future challenges associated with 
DDs: hence, the optimization of existing therapeutic methods and the development of new 
ones are important clinical research tasks. Cognitive behavioral therapy (CBT) has 
represented an innovative psychotherapy approach since its introduction more than 40 years 
ago; it has continuously developed to treat many forms of disorders and overall, it has been 
highly successful.  
When it comes to specific treatment for depression, the cognitive approach has been 
largely the same for the duration of its existence. However, until 2015 there had been no 
comprehensive efforts made to investigate CBTs treatment effects with the passing of time. 
Essentially, no-one knew if contemporary therapy was more effective, or if the effects had 
waned with time. This is the question that paved the way for the present thesis. Gaining 
insight of the temporal developments within a treatment form would potentially generate 
valuable knowledge, not only for CBT, but also for psychotherapy in general. The findings 
such investigations reveal, could lead to new understandings regarding the mechanisms that 
influence treatment effects. An investigation and evaluation of treatment effects could thus 
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contribute to the direction both clinicians and researchers essentially strive for; making 
contemporary and future psychological treatments more effective. 
 
Depressive disorders 
Depressive disorders are characterized by a set of associated symptoms, consisting of 
affective, cognitive, emotional, and behavioral changes that occur when the disorder is active. 
The most prevalent and common symptoms associated with major depression are loss of 
pleasure, loss of interest in activities, depressed mood, loss of energy, and exhaustion/fatigue. 
It is also common for patients to experience a variety of other associated symptoms, the most 
usual being suicidal thoughts, sleep disturbances, negative evaluations about themselves and 
the future, reduced appetite, irritability, poor memory and concentration, depressive 
rumination and worry, loss of sexual interest, and feelings of guilt and/or punishment. 
Individual variations in the expressed symptoms are common. Depression without 
mania/hypomania is often referred to as “unipolar” because the mood remains in one 
emotional state, in contrast to bipolar disorder.  
A significant minority of patients are afflicted by atypical depression, which shares 
many of the typical symptoms of major depression but is often characterized by improved 
mood in response to positive events, as well as weight gain or an increased appetite, and 
hypersomnia. Another frequently occurring variation in the expression of unipolar depression, 
is melancholic depression, characterized by a loss of pleasure in most or all activities, a failure 
of reactivity to pleasurable stimuli, a worsening of symptoms in the morning hours, early-
morning waking, psychomotor retardation, and excessive weight loss. There are also other 
subtypes of unipolar depression, where the current situation and/or environment is associated 
with the condition. Seasonal affective disorder is a form of depression in which depressive 
episodes typically come on in the autumn or winter, and resolve in spring, while postpartum 
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depression refers to the intense and sustained depression experienced by women after giving 
birth or while a woman is pregnant. For premenstrual dysphoric disorder, the associated 
symptoms are periods of anxiety, depression, or irritability in the week or two before a 
woman's menstruation (DSM-V, 2013). Some patients experience a more chronic presence of 
depressive symptoms, typically in a milder form. This subtype is referred to as dysthymic 
depression. A substantial number of patients experience the recurrent nature of depression, as 
approximately 6 out of 10 have a relapse (Solomon et al., 2000). Many of these are diagnosed 
with the subtype “recurrent depression”, characterized by frequently occurring episodes of 
depression, where full remission is usually achieved between episodes. There are other 
subtypes of depression as well (for example catatonic), but these are more rear. 
Clinical unipolar depression is typically categorized according to severity, with the 
ranges being mild, moderate, and severe depression. The differentiation is made by both 
severity and the number of experienced symptoms. Psychotic symptoms are associated with 
severe depression, as is usually suicide attempts. The research underpinning the current thesis, 
and its associated papers, focus on patients with unipolar depression of all clinical ranges, 
without psychotic symptoms. 
Major depression is among the most prevalent psychiatric disorders in the western 
world, with an estimated global prevalence of 4.4% (WHO, 2017). Fourteen percent of 
patients with major depression have the illness for over five years (Patten, 2006), with an 
average duration of almost 10 years (Friborg et al., 2014). A crippling consequence of 
depression is its recurrent nature, which means suffering is reinstated for the majority, many 
of whom do not return for more treatment (Andrews, 2001). Moreover, for those experiencing 
two or more episodes, depression may develop into a chronic condition (Blanco, 2010). The 
costs of depression are hence substantial for society (Sobocki, 2006; Mental Health 
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Foundation, 2010). Regular assessments of treatment effects, as well as efforts to identify the 
most efficient treatments, are therefore important. 
Unipolar depression as a psychological diagnosis has generated a vast amount of 
research over the last decades (Cuijpers, 2017). This massive focus has not decreased with the 
shift towards requirements of evidence-based treatment forms. Rather, recent scientific 
evolution put emphasis on the invention of highly accurate tools for measuring levels of 
depression and treatment effects.  
 
Diagnostic methods and criteria 
The modern method of diagnosing depressive disorders according to a set of 
associated characteristics, or symptoms, had its origin with the invention of the Diagnostic 
and Statistical Manual of Mental Disorders, first edition (American Psychiatric Association 
[APA], 1952). In the same period, the World Health Organization (WHO) revised their 
diagnostic manual, the International Classification of Diseases, Injuries and Causes of Death 
(ICD) with the intention to incorporate an official, international classification of mental 
disorders. The result was the ICD-7 (WHO, 1955). However, the reception of these early 
classifications of mental disorders did not achieve widespread international acceptance, 
leading to the subsequent developments of the DSM-II (APA, 1968) and ICD-8 (WHO, 1965) 
in the late 1960`s (Gruenberg, Goldstein & Pincus, 2005). The revision processes resulted in 
two similar diagnostical systems. However, researchers in the field of depression were not 
satisfied, stating that the lack of reliable and clear diagnostic criteria was problematic. Thus, 
in the early 1970`s the development of explicit diagnostic criteria was led by American 
researchers, resulting in a classification system named the Research Diagnostic Criteria 
(RDC). These efforts eventually culminated with the much-changed DSM-III (APA, 1980). 
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It was against this background modern cognitive behavioral therapy, as we know it 
today, developed as an anti-depressive treatment. The diagnosis of depression was initially 
based on the criteria proposed by the RDC, which were subsequently incorporated in the 
DSM-III. The new version had major changes as compared to its predecessor, the DSM-II, 
with the implementation of clear diagnostic criteria for depression being one of the more 
significant differences. The new version also represented a move away from the traditional 
labels of neurotic depression and depressive reaction, replacing them with the term major 
depression. Thus, if patients met certain criteria, or symptoms, associated with unipolar 
depression, they reached the diagnosis of major depression, a term which is still in use as of 
today. To reach a diagnosis of depression, patients had to be experiencing a loss of interest or 
depressed mood nearly every day for a period of two weeks, in addition to experiencing four 
out of eight symptoms associated with major depression. 
The diagnostic criteria for depression remained quite similar through the revisions 
made in 1987, with the DSM-III-R (APA, 1987), and in 1994 with the introduction of DSM-
IV (APA, 1994). Relevant changes consisted of moving to a requirement of meeting five out 
of nine symptoms associated with depression, including the experience of dysphoric mood or 
depressed mood or loss of interest or pleasure nearly every day most of the day during a 2-
week period. The other criteria consist of; weight change, sleep disturbances, psychomotor 
change, diminished ability to think or concentrate or indecisiveness, fatigue, feelings of 
worthlessness or guilt, and recurrent thoughts of death or suicidal ideation. The diagnostic 
criteria for unipolar depression remained intact for the latest revision of the DSM-V (APA, 
2013), with the added emphasis on functioning (depressed patients must experience 
difficulties maintaining their everyday functioning) representing a minor adjustment.  
The major changes implemented in DSM-III was not followed by similar changes to 
the ICD, which largely followed the previous templates with the publication of ICD-9 (WHO, 
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1975). The system still did not include definite clinical diagnostic criteria, although attempts 
in that direction was made with the clinical modification ICD-9-CM (WHO, 1978). One of 
the objectives were to make clinical descriptions for depression more precise, but the 
definitions were not as defined or specific as the DSM-III`s. The higher rate of precision and 
clinical focus offered by the DSM-III contributed to researchers and authors of clinical trials 
and methods to prefer this system when using diagnostic procedures. The fact that it 
originated in America probably also played a role, especially for cognitive behavioral therapy, 
which has its modern foundations in the US. In 1992 the ICD-10 (WHO, 1992) was released. 
It now incorporated similar descriptions of the depressive syndrome and characteristics as the 
DSM-IV, but still lacked the distinct clinical criteria. As such, most clinicians, and researchers 
sticked to the more user-friendly American counterpart. This impression is confirmed when 
reading and evaluating the published clinical CBT-trials for depression: The two most utilized 
methods for including participants in a trial, are either by following the criteria outlined in a 
version of the DSM, or to use the cut-off-scores collected from self-evaluation inventories 
measuring symptoms for depression. 
In summary, it may be concluded that the diagnostic criteria for unipolar depression 
have not experienced radical changes since the mid 1970`s for the DSM, and that this system 
was (and still is) the preferred diagnostic tool for CBT-trials. More pronounced changes have 
occurred for the ICD, with significant changes implemented with version 10. There have also 
recently been made adjustments with regards to the depression diagnosis with the release of 
the ICD-11 (WHO, 2019). However, given the recency of its release it is considered highly 






The psychodynamic approach 
The recognition of mood-disturbances afflicting humans dates to the very beginning of 
civil life. The term melancholia comes from the ancient Greek, who used such a terminology 
to describe the personality or traits of the typical depressed person. The Greek considered 
melancholia to be the result of having too much black bile, a hypothesized bodily fluid, in the 
system. And, while modern understanding of the depressive syndrome does not consider 
bodily fluids to be influential, the term melancholia stayed relevant also with the development 
of psychodynamic theory. 
Historically speaking, recognized and systematic psychological treatment of 
depression started with Freud`s psychoanalytic theory. Freud (1917) argued that depression 
could have many causes, including biological factors, overactive demands from the super-ego, 
and inwardly directed anger. At the same time, he also believed depression (melancholia) and 
grief were both linked to the loss of an important relationship or rejection by a parent and was 
produced via a psychological reaction from the patients’ part. The tool to treat the disorder 
was the psychoanalysis. In the following decades, psychodynamic theory dominated the field 
of depression treatment, with the work of, among others, Adler (1927), Jung (1964),) and 
Erikson (1950) developing and refining the psychodynamic approach. 
The psychodynamic branch was founded on a comprehensive theoretical base. The 
ability to explain nearly every aspect of human emotional experience, and frame it within a 
theoretical understanding, was considered a major advantage with the approach. 
Psychodynamic theory offered a completely new, complex, and exciting view on psychiatric 
disorders and mood-disturbances, which was appealing to the public. The movement also 
gave hope to the many sufferers of such illnesses, as well as their closest family and friends. 
With the forthcoming of the psychoanalysis, the main therapeutical tool for psychodynamic 
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theory, there was finally a tangible way to get better, through an approach that did not include 
being locked up or sent away.  
 Psychoanalysis for the depressed patient largely consisted of helping the patient gain 
insight into the origins of their emotional problems, thereby gaining access to solve the issues. 
The process consisted of bringing unconscious experiences (thoughts, memories, urges, and 
episodes) into conscious awareness. Via this process catharsis, or emotional release, would 
occur, and the patient would find relief from psychological distress. 
 Although psychodynamic theory did not enjoy unanimous support in the field of 
psychology, the psychoanalysis remained the main psychological treatment for depression for 
decades. However, its position became increasingly challenged from the 1950`s. Objections 
related to the lack of scientifical evidence for its treatment effects, and to the theoretical and 
clinical foundations, which were largely based on case-studies. It also became apparent that 
the psychoanalytic approach, with its focus on hidden mechanisms, drives and the 
unconscious, did not suit every patient. The timespan of treatment would also be of concern, 
with therapy often going on for years. As such, researchers and clinicians started to 
investigate other possible approaches to the treatment of depression, and mood disorders in 
general. However, psychodynamic therapy today remains a relevant and frequently used 
treatment for depression, especially with the developments of the less time-consuming, short-
term forms of psychodynamic therapy. 
 
Behavioral therapy 
The first serious alternative to psychodynamic therapy as a treatment for depression 
was offered through the developments of behaviorism. Behavior therapy (BT) became a 
dominant force in the late 1940`s and throughout the 1950s, drawing from the work of, among 
others, Skinner (1953), Wolpe (1958) and Eysenck (1960). In the aftermath of World War II, 
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there were many veterans experiencing trouble with their emotional adjustment. As such, 
there was a need for an effective short-term therapy for anxiety and depression, a task which 
the psychoanalysis was neither designed nor equipped for.  
The role of environmental cues in influencing the acquisition and maintenance of 
behavior is emphasized in BT. Conventional BT models for treating depression focus 
attention on increasing access to pleasant events and positive reinforcers and decreasing the 
intensity and frequency of events and consequences deemed to be unpleasant/negative 
(Lewinsohn, 1972). Although more frequently used for the anxiety disorders, the clinical 
approach of BT for depression also consisted of exposure training. If any neutral (objectively 
deemed as non-threatening) situation created feelings of anxiety or depression, the aim was 
for the patient to stay in the situation, or to repeat exposure until the troublesome emotions 
waned.  
Behavioral therapy offered a more pragmatic and simplistic view on psychological 
disorders, as compared to the more complex psychodynamic therapy. Essentially, behaviorism 
was based on the idea that behaviors can be measured, trained, and changed. It proposed that 
our responses to environmental stimuli determine our behavior. Unconscious mechanisms 
were not seen as relevant, neither were drives and urges. The method initially had a broad 
appeal with the public, as it was easy to understand, and did not involve large investments in 
the form of money or time. Typically, treatment lasted for less than 20 sessions. The progress 
of behavioral therapy is by many considered to be the first wave of CBT, since the latter form 
of therapy also has a significant focus on behavioral mechanisms. 
 While behavioral therapy in its purest form often led to acceptable results for patients 
suffering from anxiety, the evidence was not overwhelming when it came to treating 
depression. And, with the advances of cognitive therapy in the 1970s, BT approaches based 
purely on operant and respondent principles widely became regarded as insufficient in the 
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treatment of depression. A broader approach was sought by researchers and clinicians, one 
which could encompass both behavioral and cognitive principles in the treatment of 
psychological disorders.  
 
Cognitive behavioral therapy 
One major objection made towards both psychodynamic therapy and behavioral 
therapy was that the processes of conscious thinking, evaluation, appraisal and judgment of 
situations and stimulus largely were bypassed. From the early 1960`s researchers and 
clinicians gradually increased focus towards the influence rational thinking exerted on mood 
disturbances, including depression. 
Clinical therapist Alfred Adler was perhaps the first to point towards cognition in 
psychotherapy, with his notion of the impact basic mistakes had in creating unpleasant 
emotions for clients.  However, the earliest recognized form of cognitive behavioral 
psychotherapy was Albert Ellis` rational emotive behavior therapy (Ellis, 1957)). It`s 
underlying theory states that clients emotional distress arises from their thoughts about an 
event rather than the actual event itself. 
In the same period as Ellis did his work, psychiatrist Aaron T. Beck was working at 
the University of Pennsylvania. Having studied and practiced the psychoanalysis, Dr. Beck 
designed and carried out several experiments to test psychoanalytic concepts of depression. 
Fully expecting the research would validate these fundamental concepts, he was surprised to 
find the opposite (Beck Institute, 2021).  
As a result of his findings, Dr. Beck began to look for other ways of conceptualizing 
depression. He found that depressed patients experienced streams of negative thoughts that 
seemed to arise spontaneously. He called these cognitions “automatic thoughts.” He found 
that the patients’ automatic thoughts fell into three categories; The patients had negative ideas 
11 
 
about themselves, the world and/or the future. Dr. Beck began helping patients identify and 
evaluate these automatic thoughts. He found that by doing so, patients were able to think more 
realistically. As a result, they felt better emotionally and were able to function more 
adequately. Further, when patients changed their underlying beliefs about themselves, the 
world and other people, therapy resulted in long-lasting change. Dr. Beck called this approach 
“cognitive therapy.”, and it has also become known as “cognitive behavior therapy,” or 
“CBT.” As a result of his work, Dr. Beck is commonly regarded as the founder of CBT. 
The pioneering work of Beck and Ellis paved the way for a new direction in 
psychotherapy. The empirical and clinical support for this “second wave” of CBT was solid 
and led to a change of paradigm in psychology, with the stage set for cognitive behavioral 
therapy to become the dominant force in the treatment of a range of psychological disorders. 
This is a standing CBT still enjoys in contemporary theory and treatment for depression, 
although other directions of therapy have challenged the cognitive approach, with behavioral 
activation (Lejuez et al, 2001), interpersonal therapy (Weismann et al, 1981) and short-term 
psychodynamic therapy (Luborsky et al, 1995) all proving to be effective in the treatment of 
depression (Cuijpers, 2017). 
 
Theoretical and clinical principles 
The CBT method refers to a class of interventions sharing the basic premise that 
mental disorders and psychological distress are maintained by cognitive factors or cognitive 
processes (Hofmann et al, 2012). As posited by Beck (1970) and Ellis (1962), maladaptive 
thoughts maintain emotional distress and dysfunctional behavior, for which alleviation or cure 
is realized by changing them. When it comes to depression, the cognitive model postulates 
three specific concepts to explain the psychological substrates of depression (Beck, 1979). 
The first concept is named the “negative cognitive triad” and has been the main theoretical 
12 
 
base for understanding and treating depression. The triad involves automatic, spontaneous, 
and seemingly uncontrollable negative thoughts about the self, the world or environment, and 
the future. These automatic thoughts largely exist outside conscious awareness and are major 
determines in how people think and behave. Often, people tend to think and behave in ways 
that enhance or maintain their negative automatic thoughts. This is especially the case for 
depressed patients.  
 
The automatic thoughts are thought to be the cognitive manifestation of fundamental 
assumptions embedded in a patient’s belief system, constructs often defined as “schemas”. 
Schemas are the second ingredient in the cognitive model of depression. These basic 
assumptions are viewed as either adaptive, in which they promote good functioning and 
wellbeing, or maladaptive, exerting a dysfunctional and dysphoric effect. Cognitive theory 
states that basic assumptions, or schemas, form a personal matrix of meaning and value, and 
is the backdrop against which everyday events acquire relevance, importance, and 
significance. The developmental period is thought to be the arena where people’s basic 
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assumptions are shaped and formed, in which everyone learns rules or formulas by which they 
attempt to make sense of the world. That is, how they set goals, how they evaluate and modify 
behavior, and how they understand events in their lives.  
The third key concept in the cognitive model is faulty information processing. This 
term refers to the depressed patient`s systematic errors in thinking, that maintain the persons 
maladaptive schemas, despite the presence of contradictory evidence. Such faulty processing 
consists of overgeneralization (drawing a general rule based on one incident), selective 
abstraction (focusing on a detail while ignoring the bigger picture), arbitrary inference 
(drawing a specific conclusion in the absence of solid evidence), personalization (the 
tendency to relate events to oneself), absolute thinking (black/white dichotomous view), and 
magnification and minimization, which is the tendency to make wrong estimation of the 
effects of events.  Dr. Beck understood these faulty processes to be a thinking disorder in 
depressed patients and defined the concepts as “primitive” or “mature” modes of organizing 
reality. (Beck et al, 1979). A depressed person typically organize reality in accordance with 
the principles of a primitive organization of information.  
Thus, in cognitive theory the patient’s thought processes are viewed as most important 
for emotional wellbeing. By identifying and evaluating automatic thoughts about himself, the 
world, and the future (the cognitive triad), patients can think more realistically. As a result, 
they feel better emotionally and can behave more functionally. Further, when patients change 
their underlying core beliefs (schemas) about themselves, the world and other people, therapy 
can result in long-lasting change. The ability to maintain and enhance objective, realistic 
thinking and adaptive schemas will be enhanced by moving to a mature mode of organizing 
reality. The aim of CBT is thus both to achieve remission from symptoms by changing the 
automatic negative thoughts, and to achieve deeper change and gain resilience from new 







Cognitive behavioral therapy in its current format has, by and large, been the preferred 
choice for individual treatment of depression since the late 1970`s. The timespan of its 
existence is thus large, with over 40 years. During this time, the cognitive wave has become a 
powerful unit, both within its field of profession, and politically. The specific treatment for 
depression has not changed much during this time span though, and still lends heavily to the 
original ideas of Beck, and his original treatment manual from 1979 (Beck et al., 1979). In 
fact, over half of the trials included in the meta-analysis for paper I in the current thesis, stated 
that they applied and followed the original manual.  
The broad acceptance and use of a set manual yield an advantage when it comes to 
examining temporal trends in treatment effects based on CBT trials, as the degree of 
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standardization over the years is high. The net result is improved heterogeneity, and increased 
validity and reliability for statistical analyses. There are also potential large clinical benefits; 
Patients are receiving a well-tested and documented form of therapy, information about the 
treatment is easily accessible, and therapists have solid experience in delivering therapy. 
However, there also exist potential downsides. The use of a set manual could leave limited 
room for therapeutic freedom, creativity and adaptation to the needs of the specific patient and 
circumstances. Development over time do not occur naturally, or automatically, when 
following a set manual. Instead, practitioners and patients are reliant on officially 
implemented and published changes to the treatment manual, which in practice do not happen 
too often. The net result could be a more rigid form of treatment, which is unlikely to be 
helpful for every patient. Perhaps such factors are part of the reasons why clinical trials over 
the effect of CBT consistently show a considerable number of dropouts during treatment 
(Fernandez et al, 2015), and have a substantial number of patients classified as non-
responders (Samaan et al, 2021). 
 
Treatment description 
The following section aims to provide a clinical and theoretical description of each 
step in traditional cognitive behavioral therapy. To assist such purposes, a typical course of 
treatment for the depressed patient entering cognitive behavioral therapy is presented. The 
illustrated case is an example of CBT for depression. However, it is important to bear in mind 
that cognitive therapists are encouraged to adjust their approach according to the needs of the 
individual patient. Such adjustments may, for example, relate to the amount of time devoted 
to the different steps in therapy. Some patients, especially the more severely depressed, may 
require an extended focus on functioning and behavioral techniques, while others may require 
more time on strengthening the alliance or the release of emotions. The most important 
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objective for cognitive therapists, is to adequately cover the different areas deemed important 
in CBT for depression, such as behavioral techniques, the working alliance, education, the 
review of automatic thoughts, and pinpointing maladaptive beliefs. The order or doses of each 
ingredient do not necessarily need to follow a set formula but may rather be tailored to the 
client’s depression. 
The illustrated case report (in italics) is based on an example from the original 
cognitive behavioral manual (Beck et al, 1979), and the intention is to provide the reader with 
a bridge from theory to clinical practice. 
  
The initial interview 
 This is the first meeting between a therapist and the client, who is typically referred to 
psychological treatment by his/her general physician. The objective is to establish rapport 
(also coined the therapeutic alliance), perform a diagnostic assessment, and gain insight in the 
patient’s background, medical history, social network, as well as personal assets for therapy. 
Further, the therapist aims to collaborate with the patient to identify which problems to focus 
on initially in therapy, also labelled as target symptoms. The symptoms are formulated in 
cognitive terms, defined as maladaptive thoughts or attitudes, and the therapist provides an 
initial education about the cognitive approach to therapy. The therapist also performs an 
assessment of suicidal risk, elicits feedback about the patients experiences and thoughts about 
the first session, and plans the next step in a therapeutic course.  
 Karen is a 36-year-old married woman, working part-time in a sales-company. She 
has 3 children aged 7,9 and 14 and has been in a stable relationship with her husband for 16 
years. In the initial interview, she describes herself as a person who “can`t do anything 
right”, “is a failure as a wife and mother”, and “a burden to her family”. Karen often thinks 
about suicide to unburden her surroundings. In the initial interview, the therapist and patient 
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decide it could be helpful for her to enter a standard, 22 session weekly treatment course of 
individual CBT for depression. 
 
Sessions 1 to 3 
 The agenda for the first sessions typically involves gaining a thorough knowledge and 
awareness of the patient’s depression and review the patients’ symptoms, as indicated by 
ratings in the BDI, which is filled out before the first session (and often before every session). 
In addition, focus is on behavior and activity levels, which are reviewed. Education about the 
cognitive approach and ideas continue, and the relationship between thinking, behavior and 
affect is demonstrated. Homework is considered an essential component of CBT, and for the 
first sessions the tasks typically consist of filling out forms related to broader psychological 
functioning, reading passages or leaflets about depression and CBT, as well as following an 
established plan for appropriate activity levels. The patient is also encouraged to define 
problems she sees as contributing to her depression, and record her cognitions during periods 
of sadness, anger, or apathy, in order to elicit awareness of the relationship between thinking, 
behavior and affect.  
 In the initial sessions, Karen presented thoughts about herself as being “selfish”, 
“thinking as a child” and “insignificant in the household”. She also criticized herself for 
“not doing what I should be doing” and related this to her inability to get her youngest son 
out of bed. As part of the activity scheduling, Karen and the therapist decided a new approach 
which involved giving the boy the responsibility for getting out of bed himself. This behavioral 
intervention proved successful, and thus alleviated some of the concerns, and provided 
motivation for further adjustments in activity levels and behaviors. As activity levels and 




Sessions 4 to 8 
 After behavioral activation has been addressed, the next step is typically to focus on 
the identification and discussion of specific cognitions that leads to negative affect. These 
cognitions consist of automatic and negative thoughts about the client, the world, and the 
future (the cognitive triad). The cognitions are reviewed and challenged, with the aim of 
recognizing and correct errors in thinking. Homework consists of recording negative 
cognitions (automatic thoughts), and, if possible, record alternative thoughts or explanations. 
 Karen thought she was “a bad mother, without any benefit to her children”. She 
admitted these thoughts led to harsh levels of self-criticism. The therapist asked why she had 
such thoughts, what was her evidence? Karen replied, “the boys hate me”, “my daughter 
doesn`t respond to me”, and “my husband never gives me any feedback about my parenting”. 
The evidence was reviewed and challenged, and alternatives were identified and discussed. 
The discussions revealed that her boys had never expressed any words of hate or strong 
disapproval towards their mother. Further, Karen recognized it was not unusual for teenage 
girls to occasionally not respond to their mother and admitted that her daughter most of the 
time was responsive. The patient also deemed it plausible that the lack of feedback from her 
husband could be because he had no larger objections towards her parenting. As a result of 
these more realistic reviews of her automatic thoughts, Karen felt less sad and critical of 
herself. 
 
Sessions 9 to 17 
 After reviewing and challenging automatic thoughts, the next step in therapy is to 
address the underlying assumptions that assist in maintaining negative thoughts. The therapist 
helps identify such maladaptive attitudes, which consists of deeply embedded beliefs. 
Homework in this stage of therapy typically involves elements that may counter the effects of 
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the maladaptive attitudes, for example making lists where positive actions and thoughts are 
written down, memorized, and practiced in real life settings. 
 In therapy, Karen recognized that her tendency to criticize herself was driven by strict 
rules for behavior and functioning that she had embedded in her personal understanding of 
herself. These “should do`s” were almost impossible to satisfy, thus leaving her feeling 
worthless and inadequate. In addition, her strict internal rules led her to not focus on her own 
wants and needs, thus preventing activities and thoughts that may enhance positive feelings. 
Karen’s rules of “I should prioritize other people’s needs” and “I should perform all tasks 
perfectly” were thus identified as maladaptive beliefs and challenged and corrected over 
several sessions. As she gradually practiced not doing every task in a perfect manner and 
identified and prioritized doing some of the stuff she wanted, she gradually experienced less 
thoughts of self-criticism. 
 
Sessions 18 to 20 
 At this stage of therapy, the main interventions have been well practiced, and the 
patient is becoming more adept in identifying and challenging maladaptive thoughts and 
assumptions by him/herself. Patients often feel more energetic, less depressed and are ready 
for functional changes in their lives. Thus, the focus of therapy turns to recognizing and 
implement new (and adaptive) skillsets, hobbies, occupations, educations, or other activities 
that are considered helpful. At the same time, it is important to be aware of a return of the 
problematic areas, as the endeavor of new tasks often makes challenges resurface. Homework 
may consist of identifying and discussing future plans with friends or families, and to follow a 
structured plan for implementing the desired actions. 
 As Karen was getting more acquainted to her own needs and preferences, she 
gradually recognized a desire to start playing football, a sport she had enjoyed in her youth. 
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She discussed this with her husband, who was supportive, and together they figured out the 
practical aspects of such an endeavor. As the first training approached, some of Karen’s 
negative thoughts resurfaced, and she criticized herself for being selfish and not prioritizing 
more important tasks. These thoughts were addressed in therapy, and between sessions by 
Karen herself. Although not completely gone before the first training session, her maladaptive 
thoughts were reduced to an extent that allowed her to attend.  
 
Sessions 21 and 22 
 The final sessions of therapy focus on consolidating the treatment progress and 
preventing relapse. This is achieved through revisiting the previous stages of therapy and 
make sure the patient has established a sound platform to continue monitoring and reviewing 
his/her maladaptive thoughts, should they resurface. Relapse is sought to be prevented via 
enhancing the patient’s belief in a sustained outcome, reassure the patient that he/she has the 
availability of further boosting sessions if things get bad, as well as scheduling follow-up 
sessions at timely intervals. The tapering off the last sessions is also seen as helpful to prevent 
relapse, and the final sessions should thus be scheduled twice a month, rather than weekly. 
 Towards the end of therapy, Karen felt much better and reported not being depressed 
anymore. This was reflected in the BDI, where her score now was 7, which is at a non-clinical 
level of symptomology. She expressed concerns about no longer having the opportunity of 
frequent treatment sessions but was largely reassured with the scheduling of follow-ups at the 
intervals of 1, 2, and 6 months. 
 
Follow-up 
 In follow-up sessions, focus is typically directed to assess the present situation, and 
evaluate if there has been regression with regards to any part of the previous problematic 
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areas. The patient`s continued ability to use treatment tools is also checked, and rehearsal 
implemented if deemed necessary. Treatment is typically terminated after two or three follow-
up sessions. 
 Karen remained nondepressed throughout the follow-up period and noted with 
pleasure that she generally felt more confident and was more relaxed in her role as a parent 
and wife. Her score on the BDI was 5 at the last session of follow up. Her previous automatic 
thoughts still occasionally resurfaced, but Karen had now incorporated techniques that 
enabled her to fend of such thoughts quite rapidly. She felt ready for terminating therapy. 
 
Treatment effects and further developments 
A large amount of research has confirmed the efficacy of classical CBT in treating 
depression. Meta-analyses published in the 1980s (Dobson, 1989), the 1990s (Hollon, 
Shelton, & Loosen, 1991), and after 2000 (Cuijpers et al., 2008), concluded that CBT had a 
high treatment efficacy. Effect sizes (ES) for individual CBT have recently been proven to be 
strong at post-treatment, with ranges of g = 1.37 to 1.89 observed across different analytic 
conditions (Johnsen & Friborg, 2015; Cristea et al, 2017). Cognitive behavioral therapy has 
often (but not universally) been found to maintain substantial parts of its treatment effects. 
Follow-up at 1-year typically reveals relatively comparable scores as those measured at post-
treatment (e.g., Kovacs et al, 1981; A-Tjak et al, 2021). The magnitude of CBT’s enduring 
effects has also been found to be at least as large as keeping patients on continuation anti-
depressive medication (Hollon et al, 2005; Dobson et al, 2008). 
Later variations of the cognitive method have been developed, building on the 
foundations of CBT. The most well-known are CBT combined with mindfulness (Segal, 
Williams, & Teasdale, 2002), integrated cognitive therapy with elements of interpersonal 
therapy (Castonguay, 1996), and meta-cognitive therapy (Wells, 2000), which represent 
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further innovations in CBT. These newer forms of CBT, typically referred to as the third wave 
of cognitive therapy, have exhibited promising efficacy in clinical trials, however, few studies 
have demonstrated these innovations to be significantly more effective in treating DDs than 
classical CBT (e.g., Ashouri et al., 2013; Manicavasgar, Parker, & Perich, 2011).  
 
Treatment fidelity and adherence 
Therapists conducting CBT are expected to have good knowledge of the general 
cognitive principles, as well as having the necessary therapeutic skills to translate knowledge 
into practice when delivering therapy. These skills are usually achieved via specific training 
and guidance, or through formal education and courses. The main goal with such training is to 
ensure that therapy is conducted as closely in line with the cognitive principles as possible, 
and thus not consisting of any approaches, angles, interventions, or elements that are not 
cognitive oriented. Purity in treatment is the objective. A treatment purely consisting of 
elements derived from CBT is thus considered to have the highest degree of treatment fidelity, 
or integrity. 
Treatment fidelity and treatment adherence are often used interchangeably as terms 
relating to the therapists` ability to follow the treatment manual as carefully as possible. When 
a therapist precisely follows each step of the manual, through each session of therapy, in the 
manner described by the manual, adherence is at its highest.  
For researchers and clinicians affiliated with the cognitive branch of psychotherapy, 
treatment fidelity and adherence to the manual are traditionally stressed to be factors of high 
importance for therapeutical outcome. The general opinion is that higher degrees of fidelity 
and adherence correlates with better outcomes for the clients. As such, different scales have 
been developed to measure fidelity and adherence, which researchers are encouraged to use 
when conducting clinical trials. One of the earliest, and most frequently utilized scales, is the 
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cognitive therapy scale (CTS: Young & Beck, 1980). However, despite available scales, there 
has been a limited amount of research on the correlation between the degree of 
adherence/fidelity and treatment outcomes, or effect sizes. No meta-analyses have attempted 
to quantify and measure this relationship precisely. The most probable reason for this gap 
relates to the lack of a standardized procedure regarding which scales to use, and how to 
adequately report results from research trials.  
The lack of quantifiable data was indeed the main reason why the meta-analyses in the 
current thesis could not precisely investigate the relationship, and potential interaction, 
between adherence, effects sizes and time for publication. However, for individual cognitive 
therapy, paper I (Johnsen & Friborg, 2015) found that there was no difference in outcome for 
trials that did use a measure of adherence and fidelity, versus trials that did not use one. This 
finding does however not give a clear answer as to whether higher degrees of fidelity are 
related to better outcomes.  
 
Group cognitive behavioral therapy 
 Group psychotherapy is a common treatment modality for many disorders, including 
depression. Group therapy may be defined as a meeting of two or more people (usually six to 
eight persons) working toward a common therapeutic goal. Group cognitive behavioral 
therapy (GCBT) is based on traditional cognitive therapy (Beck et al., 1979) and typically 
includes elements such as case formulations, reviews of automatic thoughts and maladaptive 
beliefs, and analyses of antecedent events or situations and associated behaviors and 
cognitions with fellow group members, all of whom contribute with their personal 
experiences and point of views. In addition, homework, conceptualization of problems, and 
group attention to self-defeating beliefs are common elements within this format. 
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GCBT gained popularity as a treatment for depression in the late 1970s and showed a 
promising degree of efficacy (e.g., Beck et al., 1979; Shaw, 1977). Although the focus in 
modern psychotherapy, by and large, has been the individual format, the increasing number of 
studies during the last decade on group therapy as a viable anti-depressive treatment (e.g., 
Hans & Hiller, 2013; Huntley, Araya, and Salisbury, 2012) indicates a shift in interest 
towards the group format. Group cognitive behavioral therapy is considered short-term, with 
treatment courses typically ranging from 8 to 20 sessions. 
Cognitive treatment methods and principles are clearly defined and well understood by 
researchers and clinicians, hence facilitating homogeneity with regards to the use of treatment 
techniques, ingredients, and assessment measures across studies. This methodological 
allegiance allows valid and reliable comparisons of effect sizes for GCBT interventions. The 
effectiveness of GCBT for depression has been demonstrated in several meta-analyses (e.g., 
Huntley et al., 2012; McDermut, Miller, & Brown, 2001; Okumura & Ichikura, 2014). Recent 
estimates of ESs have revealed ranges of g = 1.14 to 1.56 across statistical conditions 
(Johnsen & Thimm, 2018). Studies comparing individual versus group CBT for depression 
have typically reported the latter as less expensive (Tucker & Oei, 2007; Vos et al., 2005) but 
not necessarily less effective (Hans & Hiller, 2013; Khoshbooii, 2012) than the former. A 
recent meta-analysis (Burlingame et al., 2016) showed no differences in outcome between 
individual and GCBT for depression in studies in which the treatment, the patients, and the 
doses (number of sessions) were identical. Findings like these highlight the potential 
importance of implementing group psychotherapy formats in addition to the individual 
treatment format. However, although individual and group CBT share the same treatment 
philosophy and therapeutical techniques, there are differences between the two formats that 
may influence the effects of these treatment modalities, necessitating the need for separate 
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analyses to optimize statistical reliability and validity. For example, group cohesion and 
normalization are potential therapeutic factors that are specific to GCBT (Whitfield, 2010). 
 There exist large variations when it comes to using a treatment manual in GCBT. 
Trials have typically either invented their own manual, modified existing treatment protocols, 
or been performed without following a set manual. This does not necessarily mean that 
adherence to the general cognitive principles is compromised but implies that measures of 
adherence to a set manual are difficult to implement, or not applicable. Also, with such a 
varied approach to therapy within the field, thorough and precise statistical evaluations of the 
relationship between treatment fidelity and ESs are difficult to perform.  
 
 Treatment course 
 Although several researchers and clinicians have developed manuals for conducting 
GCBT, the ingredients and techniques are similar and follow cognitive theoretical principles. 
The variations usually concern how much time (number of sessions) that is devoted to each 
element, the order in which the cognitive techniques are presented, which themes to focus on, 
and how much time is allocated to the group conversations. The two latter variables largely 
depend upon the characteristics and setting of the group. In the following text, a typical course 
of GCBT for depression is described, based on a tested manual (Schaub et al, 2006). 
Sessions 1-3 are predominantly of psychoeducational character. The ingredients here 
consist of an introduction to CBT, the cognitive principles, and the therapeutical concept, as 
well as education about symptoms, and a focus on how to behave and not to behave in the 
group setting. Information about antidepressants, medication and alternative forms of therapy 
is provided, and the vulnerability stress model is presented. 
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Sessions 4-6 focus on behavior and behavioral activation. Information is provided 
about the vicious cycle of depression and the depression spiraling effect, and the balance and 
implementation of activities are discussed. Positive activities are planned and structured. 
Sessions 7-10 tunes into the cognitive part, with information provided regarding the 
cognitive triad of depression and the cognitive model. Cognitive distortions and the process to 
change them are discussed, and depressive rumination thematized in the group setting. Core 
beliefs are discussed, identified, and sought changed. 
Sessions 11 and 12 focus on the prevention of relapse, through learning how to 
identify early warning signs of depression, how to deal with crises, and how to handle a 
depressive mood without the guidance of a group or a therapist. Finally, treatment is 
summarized and concluded. 
 
Mindfulness-based cognitive behavioral therapy 
 Recently, mindfulness-based cognitive therapy (MBCT; Crane, 2009; Segal, Williams, 
& Teasdale, 2002; Segal, Williams, Teasdale, & Kabat-Zinn, 2013) was developed as a 
modification of CBT with the primary intent to prevent the relapse and recurrence of 
depressive episodes in individuals who had recovered from depression (Lau, 2016). The 
approach was well-received amongst clients and clinicians, and soon trials and treatments 
were extended to cover all clients and types of depression, except perhaps the most severe 
cases.  This shift has led to a mixed approach for researchers and clinicians conducting 
MBCT, where some trials focus on preventing relapse and recurrence, while other trials` main 
goal is to treat unipolar depression in a comparable manner as the traditional therapies of CBT 
and GCBT. Based on recent published research and available literature, as well as clinical 
developments, the general impression is that MCBT is moving towards a more encompassing 
treatment of depression. 
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  MBCT is a manual-based treatment that combines exercises in mindfulness training 
with cognitive behavioral techniques. Both therapies are more similar than different, working 
to help patients better control their thoughts and emotions and thus their responses to them. 
The mindfulness elements of MBCT, including breathing and meditation exercises, are 
thought to rebalance networks within the brain to help patients better control the body’s 
automatic responses to the stresses associated with negative thoughts or emotions. The 
integration of mindfulness practice with cognitive interventions distinguishes MBCT from 
other mindfulness-based interventions (MBIs), such as mindfulness-based stress reduction 
(Kabat-Zinn, 1990). The overall goal of MBCT is to increase metacognitive awareness (Lau, 
Segal, & Williams, 2004) and, thereby, reduce cognitive and emotional reactivity (Gu, 
Strauss, Bond, & Cavanagh, 2015). Studies have shown that MBCT is effective in reducing 
the relapse and recurrence of depression (Kuyken et al., 2016; Piet & Hougaard, 2011). 
 The treatment and clinical trials of current unipolar depression with MBCT usually 
follows the original manual by Segal et al. (2013). This is in contrast with GCBTs more 
varied approach to using a treatment manual. MCBT is delivered in a group format with up to 
12 participants and one or two instructors. After an individual pretreatment interview in which 
the participant’s history of depression is discussed and information about MBCT is provided, 
the treatment consists of eight weekly two-hour sessions (Baer & Walsh, 2016).  
Several meta-analyses have shown that mindfulness-based interventions (MBIs) in 
general (e.g., Goldberg et al., 2018; Goyal, Singh, Sibinga, & et al., 2014; Hedman-Lagerlöf, 
Hedman-Lagerlöf, & Öst, 2018; Wang et al., 2018), and MBCT in particular (Galante, 
Iribarren, & Pearce, 2013; Lenz, Hall, & Bailey Smith, 2016), are effective in reducing 
depressive symptoms. For example, a recent meta-analysis of randomized controlled trials 
(RCTs) observed effect sizes of d = 0.59 for MBIs vs. no treatment and d = .38 for MBIs vs. 
active control conditions (Goldberg et al., 2018). For MBCT specifically, similar, or higher 
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ESs for the reduction of depressive symptom severity have been reported. For example, 
Hofmann et al. (2010) observed an average ES of 0.85 (Hedges’ g) in nine pre-post studies. 
Lenz et al. (2016) reported mean ES of g = 0.76 and 0.54 for MBCT vs. waitlist or no 
treatment and for MBCT vs. alternative treatments, respectively, in RCTs. Recently. Goldberg 
et al. (2019) found that MBCT was superior to non-specific control conditions (d = 0.71) at 
posttest but not more effective than other active treatments (d = 0.00). 
 
Measuring devices for depression 
Unipolar depression as a psychological diagnosis has generated a vast amount of 
research over the last decades (Cuijpers, 2017). This massive focus has not decreased with the 
shift towards requirements of evidence-based treatment forms. Rather, recent scientific 
evolution put emphasis on the invention of highly accurate tools for measuring levels of 
depression and treatment effects. From the beginning of the 1960s many measuring devices 
for depression have been developed, all with the intention of measuring levels of depression 
in the most valid and reliable manner possible. While the use of some instruments has faded 
with time, as is the case for the Zung Self-Rating Depression Scale (Zung, 1965), others, like 
the Montgomery-Åsberg Depression Rating Scale (Montgomery & Åsberg, 1979) have been 
utilized in relevant areas. The latter instrument has been a highly popular tool for general 
practitioners throughout the last decades. Despite efforts in development, few instruments 
were deemed to encompass both the necessary clinical and statistical qualities to meet the 
requirements of modern research methods. However, there were two noticeable exceptions: 






The Beck depression inventory 
The Beck Depression Inventory (BDI; Beck et al., 1961), is a self-report rating 
inventory that measures 21 different attitudes, symptoms, and behaviors that characterize 
depression. The internal consistency is generally good with high alpha coefficients (e.g., .86 
and .81 in psychiatric and non-psychiatric populations; Beck, Steer, & Garbin, 1988).  
The Beck Depression Inventory originally took upon itself a huge task, being devised 
to measure as many as possible of the common symptoms related to major depression 
disorder. The mission also included a “one-size fits all” objective, where reliable 
measurements across diagnostic categories and levels of unipolar depression, could be 
achieved by a single self-evaluation form consisting of 21 items. The items themselves had a 
broad scope, ranging from cognitive and behavioral symptoms to somatic and emotional ones. 
Soon after the invention of the BDI, a plethora of researchers and clinicians put the tool to its 
test, via both clinical trials and statistical and methodological analyses. And, although some 
minor flaws could be identified from time to time, the conclusion was that this form was the 
real deal. The BDI proved itself as an easily accessible, low maintenance tool, with enough 
precision to make statistical comparisons valid, and clinical information highly relevant.  
With time, the original BDI has been revised three times, with modest to moderate 
changes to each version. Compared to its predecessor (the BDI-1a; Beck, Steer, & Garbin, 
1988), the latest version (the BDI-II) has incorporated an item measuring hypochondriasis, 
changed the timeframe of symptoms from one week to two weeks, and put even more 
emphasis on measuring all diagnostic criteria related to depression (Beck et al, 1996). This 
latest revision was largely inspired by changes in diagnostic procedures for depression, as 
outlined by the Diagnostic and Statistical Manual of Mental Disorders IV (APA: DSM IV, 
1994). One of the stated aims from the inventors of the BDI, was to connect the inventory 
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closely to the diagnostic manual, with previous revisions being made shortly after a new 
edition of the manual has been released.  
The updated version of the inventory has been shown to have solid psychometric 
qualities. For example, Beck et al (1996) found high alpha coefficients (.91), and high test-
retest reliability (r = .93) across several samples. The BDI has moderate to high correlations 
with other inventories measuring depression. For example, the Hamilton depression rating 
scale (HDRS; Hamilton, 1960) has been found to correlate between .5 to .8 with the BDI 
(Beck et al., 1988; Beck et al., 1996). The criterion validity of the BDI has also been 
examined. Ambrosini et al (1991) investigated the concurrent validity on initial BDI-scores, 
and found high sensitivity, specificity, and predictive powers of 86%, 82%, and 83%, 
respectively.  The predictive validity of the BDI was extensively investigated in a study by 
Burkhart et al (1984), where 600 students filled out the BDI with varying intervals. The 
results showed that scores on the BDI declined in a faster rate with repeated administration, 
leaving the authors to suggest that the BDI does not discriminate between stable and unstable 
forms of depression.  
The BDI shares theoretical principles and foundations with cognitive behavioral 
therapy. As such, since the 1970`s almost all studies of CBT for depression have utilized the 
inventory as their primary outcome measure. This high degree of standardization offers a 
major advantage when it comes to examining time-trends and is thus the main reason why the 
BDI was the primary outcome measure for the papers and analyses included in the present 
thesis. 
 
The Hamilton depression rating scale 
  While the BDI is generally held in high regard for its psychometric qualities, there are 
also challenges and potential problems linked with self-report inventories. Patients could have 
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difficulties understanding the general instructions or wording of the items correctly, or they 
could distort their answers (even lie). One way to eliminate the potential confounding effects 
connected with subjective self-reports, is to have an objective rating of the patients’ 
symptoms. This is what the Hamilton Depression Rating Scale (HDRS; Hamilton, 1960) 
offers. The HDRS is a clinician administered rating scale, measuring similar characteristics of 
depression as the BDI. The device has good psychometric qualities, with a generally high 
inter-rater reliability, where coefficients typically exceed .84 (Hedlund & Vieweg, 1979). The 
correlation between the BDI and the HDRS is in the moderate to high range, r = .5 to .8 (Beck 
et al, 1988; Beck, Steer, & Brown, 1996). 
While the use of other depression measures in treatment trials have been varied, the 
HDRS has been utilized more frequently, in conjunction with the BDI or by itself. Thus, the 
HDRS was an obvious and natural choice as the secondary outcome measure in the relevant 
meta-analyses and papers building up this thesis. 
 
Meta-analysis and meta-regression analysis 
As the field of psychotherapy gradually moved towards a more prudent and rigorous 
scientific approach during the 1950`s and 60`s, researchers typically used traditional and 
trusted statistical methods based on the principles of correlation when investigating treatment 
effects. Research trials consisted of small samples with 4-10 participants being enrolled in a 
treatment program, where the intervention was the treatment method to be investigated. 
Outcome measures varied to a large extent, but the common idea was to gather clinical 
information at the start and finish of treatment, and then compare the registrations. This was 
typically done through a t-test, and the results indicated to which degree an intervention was 
effective in easing the participants suffering. The approach quickly gained approval, 
especially from the adherers of the modern psychological fields of behavior therapy and 
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cognitive therapy. The rising popularity contributed to an increase in treatment trials, which 
increasingly were conducted with similar methods, and were investigating similar 
interventions (for example BT). However, the outcomes of such trials often revealed 
differences, despite very similar approaches and research designs. The need of a method to 
combine and summarize the results become apparent. Thus, in the late 1970`s, the research 
field of psychology experienced a breakthrough, via the work of Gene V. Glass and others. 
Glass and his associates’ efforts culminated with the first recognized study where results from 
different treatment trials were combined, and the outcome was a summarized result derived 
from the included trials (Smith & Glass, 1977). The term meta-analysis was selected to 
describe the method, and the procedure soon became the gold standard for summarizing 
research findings. This is a standing the method still largely enjoys in contemporary health-
sciences. 
In the beginning, meta-analytical models and programs were designed and utilized to 
summarize effect sizes, which allowed comparisons between treatments to be made on a 
higher level, with more included patients, and vastly enhanced validity and reliability.  
However, the earlier models were quite crude. The ability to process and analyze several 
variables simultaneously and check their potential moderating influence on effect sizes 
(treatment outcome) was not possible or did not yield accurate results. This changed with the 
invention of meta-regression analysis, a statistical procedure largely inspired by the works of 
Cathrine S. Berkey (Berkey et al, 1995). The method allows researchers to investigate the 
degree of influence different variables exert on the outcome measure of choice and has 
gradually become implemented in the field of psychological research from the early 2000`s 
and onwards. One of the computerized programs based on the method of meta-regression 
analysis, is the CMA (Comprehensive Meta-Analysis), which is the statistical program 
utilized for the meta-analyses comprising the present thesis. 
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 Advantages and statistical considerations 
The benefits of using meta-analytic methods to summarize clinical results are well-
known (Borenstein et al., 2009). By accessing a large pool of studies and assigning the 
individual studies different weights according to their sample size, the potentially troublesome 
role of individual studies indicating weak or even contradictory results is minimized. A meta-
analysis is also preferable in situations where studies are well-defined or similar in terms of 
patients, diagnoses, intervention procedures, and the measurement instrument used (e.g., the 
Beck Depression Inventory), thus simplifying the quantification of the effect size 
considerably. Moreover, meta-regression approaches may be used to identify potential 
sources of co-variation between study-related factors and treatment effects. 
 There are several available methodological and statistical options when performing 
meta-analyses, all of which could influence effect sizes (ES). After determining which 
variables and phenomenon to be investigated, and which outcome measure to be used, the 
procedure of calculating ESs typically utilizes either the pre-post within-group, or the between 
group (controlled trial). For studies that do not include a no-intervention control group, a 
standardized mean difference (SMD, also denoted Cohen’s d) is calculated for the 
intervention group (Mpre – Mpost, divided by the standard deviation -SD- of the change 
score). Often, the Hedges g correction is made to the SMD, which reduced the SMD for 
studies having small sample sizes (Hedges & Olkin, 1985).  
For the controlled trials (CT), or the between group condition, effect sizes are 
calculated from the difference between the pre- and post-test scores on the outcome measure 
(for example, the BDI and the HDRS) for the intervention group and the control group, 
respectively, and then standardized using either the change scores, or the post scores. When 
examining trials consisting of few participants, standardization using change scores is usually 
preferred, because studies including a smaller number of participants might contain pre-
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intervention differences despite randomization. The change score variant is less sensitive to 
such differences compared to standardization using post scores. Another potential advantage 
of using the SD for change scores is that the effect sizes for CT studies are estimated similarly 
as studies without a control group (within-study designs). Standardization by change scores 
also is recommended when the objective is to assess change relative to pre-intervention scores 
(Kulinskaya et al., 2002), and has frequently been the preferred method to quantify treatment 
effects in meta-analytic reviews of psychotherapy (e.g., Abbas et al., 2013; McGuire et al., 
2014; Zoogman et al., 2014). However, one limitation is that change scores require 
knowledge of the pre-post correlation, which typically is not reported in the individual trials. 
As such, this index often needs to be imputed. The utilization of a controlled trials condition 
is usually the preferred method when performing a meta-analysis on treatment effects. This 
method yields significantly lower scores of heterogeneity compared to within group designs, 
and typically shows lower (and less inflated) treatment effects (Pallesen et al., 2005).  
Another important consideration is whether to apply either a random effects model, or 
a fixed effects model. As the random effects model has the assumption that the true effect 
sizes would vary among studies due to the study-related factors, this is most often the choice 
when comparing and calculating treatment effects. Employing a random-effects model 
increases the generalizability of the results (Field, 2003). 
 
Disadvantages and alternative models 
Although the standard meta-analysis and meta-regression analysis offer precise 
methods for summarizing data, the designs also have inherent disadvantages, as compared to 
other modern methods such as network meta-analysis and individual participant data meta-
analysis (IPD). The perhaps biggest issue relates to the level of data processing. The raw data 
for meta-regression analyses consists of the aggregated data for treatment trials. This means 
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that data from the individual participants are not considered. However, aggregate data are 
sometimes not available or poorly reported in articles and are more likely to be reported when 
statistically or clinically significant, amplifying the threat of publication bias and within study 
selective reporting (Riley et al, 2010). On the other hand, individual participant data facilitates 
standardization of analyses across studies and direct derivation of the information desired, 
independent of significance or how it was reported. Individual participant data may also 
include a longer follow-up time, more participants, and more outcomes than were considered 
in the original study publication. 
Another common issue with aggregate meta-analyses, is the vulnerability for small 
samples to achieve effect sizes that may not be representative. This issue is not relevant for 
the IPD-approach. The method may thus offer a more detailed, precise, and robust approach 
for summarizing data, which is why contemporary researchers are increasingly moving in that 
direction. However, it should be noted that for many study-designs the IDP meta-analysis is 
not a realistic option. One case in example, are the analyses building up the current thesis. The 
temporal focus means that available data must be collected from studies across a large 
timeframe, with the oldest articles exceeding 40 years. It is thus not conceivable that all the 
relevant data is still intact or available, and there would most likely be difficult to get the 
necessary approvals for gaining access to the individual participants’ data.  
 When it comes to comparing different treatments simultaneously, the conventional 
meta-analysis is limited. It can only compare two interventions at a time, and mainly those 
evaluated directly in head-to-head trials. Thus, if the objective is to analyze the effectiveness 
of several treatments in one go, the network meta-analysis is the preferred option. This 
method offers a potential more efficient and comprehensive way of comparing treatments, and 
its appliance is therefore rising within the field of medicine and psychology. However, this 
method is not appropriate for some designs or research questions. If the main objective is to 
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evaluate potential moderators influence on any measured phenomenon (for example an effect 
size), the meta-regression analysis and the IPD meta-analysis are considered better options.  
 Researcher allegiance is a variable that may influence the design, procedure and 
outcome of any research trial or study. Meta-analyses should not be considered an exception, 
even though they, historically speaking, may seem to have been regarded as exempt from this 
phenomenon. As such, the amount of literature and studies on the topic is very limited, 
bordering non-existent. The lack of interest in such a phenomenon seems strange, as there are 
many obvious manners in which allegiance could influence a meta-analysis, ranging from the 
selection procedure itself, to methodological and statistical choices, culminating in if/how to 
communicate any findings. This is a topic where future attention is welcomed.  
 
Treatment effects and effect sizes 
 In the context of data analysis, relationship typically refers to the correlation between 
two characteristics or attributes for a set of analysis units. This also apply for trials in 
psychotherapy, where the correlation between the variables “treatment” and “outcome” is the 
relationship of interest. Outcome may be defined in many ways, including self-report 
inventories, and/or ratings made by a clinician. The invention of the term correlation is 
ascribed to Sir Francis Galton, and his work in the late 1880`s (Huberty, 2002). Pearson 
(1905) developed the concept further and labelled the correlation ratio as “Pearson`s “r, or 
simply “r”, as is the most usual prefix today. The correlation ratio was the underpinning of 
further and more complex statistical developments, such as t and f tests of significance. 
 In the two-group mean-comparison situation, the typical effect size index considered is 
a standardized mean difference (SMD). Such an index was first proposed by Cohen (1962), 
with the term “d” representing effect size as the difference between two groups, as a 
consequence of any moderating variable (for example, implementation of cognitive 
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behavioral therapy). Effect sizes below 0.2 are considered low, moderate effects are observed 
up to 0.5, large effects up to 0.8, and very large effects from 0.8 and upwards. Further refining 
of Cohen`s d was done by Hedge (1981), who corrected the d`s inhered bias towards small 
samples, with his index Hedge`s g. For trials and meta-analyses measuring the efficacy of 
CBT, the expression of the SMD as d or g has been common practice.  
Although being an easily understandable and accessible expression of treatment 
effects, the measures of d or g are not perfect, and are specifically vulnerable for small sample 
sizes, where effect sizes are at risk for being inflated. This typically happens when all, or the 
vast majority of, members of a small sample (2-20 participants) report good effects from a 
treatment trial, without any significant variability within the group. For example, if all 10 
clients included in any depression trial had a reduction pre-post treatment from 30 to 3 points 
on the BDI, ESs would be in the range of 7-8 g, which is a value that could be hard to make 
any statistical or clinical meaning from. This phenomenon is unlikely to happen with large 
samples, in which the principle of random distribution usually means there will be a larger 
spread in scores and outcome among participants within a treatment trial. Standard deviations 
will increase, and the observed ESs decrease. When performing a meta-analysis based on 
trials which include small samples, this is important to be aware of. Modern computerized 
programs have got sophisticated statistical procedures that are designed for adjusting the 
possible bias associated with smaller sample sizes, such as the Hedges` g calculation. 
However, in common practice researchers still come across ESs that remain very high, and 
thus possibly are inflated. Considerations should in such instances be made as whether the 
study should be excluded or not. This is especially important if the resulting analysis leads to 
any significant findings. In such circumstances, a control-mechanism should always be 
implemented, usually in the form of a re-analysis on the same dataset without the outlying 
study included.  
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Another factor that may exert influence on ESs, is the stringency in which the 
conditions of the treatment trials are conducted. It is wise to be aware of a potential inverted 
relationship; when stringency increases, ESs are vulnerable for a decrease. Higher demands 
can, for example, occur as requirements of a control group, implementing the same exact 
circumstances for each participant/therapist/rater in a trial, and incorporating a strict selection 
procedure. While traditionally difficult to measure precisely, a rating of study quality is 
thought to provide an index which is relevant for pinpointing the level of stringency. When 
calculating aggregated effect sizes, it is thus recommended to utilize a reliable measure of 
study quality. In this way, statistical checks can be performed to determine if study quality 
(and stringency) in any way covariate with ESs. If such a relationship does indeed exist, 
caution must be implemented when interpreting the results. 
 
Clinically meaningful change 
The term effect size is a statistical expression of treatment effect. As such, it is not 
possible to translate ESs directly into an accurate number of patients who feels subjectively 
better or have recovered from a diagnosis. Further, to describe the robustness of any findings 
in a research trial, the preferred term is “statistically significant”. Unfortunately, the term 
statistical significance does not automatically equate to a meaningful or practical effect. Some 
statistically significant effects are meaningful, yet others are not. Because statistical 
significance and practical significance are often conflated when one interprets research 
findings (i.e., statistical significance is assumed to establish practical significance), 
researchers are now encouraged to explicitly interpret the practical import of statistical results 
by providing estimates of effect sizes (Schuele & Justice, 2006). Effect-size estimates are 
values that characterize the magnitude of an effect or the strength of a relationship. They do 
not necessarily give information about meaningfulness. Thus, readers of research articles must 
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consider two issues to decide whether research results are sufficient to have an impact on 
clinical practice: First, are the results statistically significant? Second, are the results clinically 
meaningful or relevant?  
To make informed recommendations about to which degree a treatment is of benefit to 
patients, clinicians and researchers should thus figure out what constitutes a clinically 
significant treatment effect. This can be done by establishing the minimal clinically important 
difference (MCID) on the outcome measure, i.e., the smallest difference in score considered 
clinically worthwhile by the patient. MCID is a patient-centered metric that captures both the 
magnitude of improvement and the value the patient places on that improvement (McGlothlin 
& Lewis, 2014). For the BDI, the main outcome measure for depression, MCID has 
traditionally been established by clinical consensus or recommendations. A change of three 
points on the inventory is typically considered to indicate that MCID has occurred (NCCMH, 
2004). Although frequently utilized, this way of determining clinical meaningful change has 
not been empirically tested, nor validated. Furthermore, utilizing recommended thresholds 
have the disadvantage of ignoring the subjective point of view of the patient. This matter has 
been addressed in recent research, where the patient’s subjective feelings of global 
improvement has been measured against improvements on the BDI-II (Button et al, 2015). 
This comprehensive study indicated that MCID is best measured on a ratio scale as a 
percentage reduction in symptom score. The researchers estimated that the MCID on the BDI-
II corresponds to a 17.5% reduction in scores from baseline. For individuals with longer 
duration depression who had not responded to antidepressants, the corresponding estimate 
was 32%. As such, baseline severity is a major factor when determining MCID. For patients 
with a baseline score of 20 on the BDI, the recommended 3-point reduction does indeed 
represent clinical meaningful change. However, if baseline is a score of 40 points, the clinical 
recommendations are not entirely accurate, nor applicable. 
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The Hamilton Rating Scale for Depression has also recently been evaluated for 
clinically meaningful change (Rush et al, 2021). Here, the researchers found that a reduction 
in symptom score > 4 constitutes a clinical meaningful change for patients with non-psychotic 
major depressive disorder. A change in symptom scores of 7 or more was determined to be 
clinically substantial. 
What impact on effect sizes will a change in three points on the BDI, or 4 points on 
the HRSD, exert? The answer is “it depends”. This is due to differences in the factors 
determining ESs, which will vary from study to study according to the individual 
characteristics of a trial. However, estimates based on the datasets for the meta-analyses 
performed in the current thesis, indicate that a change in 3-4 points for the BDI and HRSD 
roughly translates to a difference of 0.2-0.4 g in ESs. These estimates show that a clinically 
meaningful change only qualify as a rather weak effect size. Thus, if patients in a research 
trial experience reductions from pre-treatment scores of 23, to post-treatment scores of 19, 
this is considered clinically meaningful, but will most likely equate to statistically low effect 
sizes. It should also be observed that such a reduction does not imply any diagnostical change; 
the patient still (most likely) meets the diagnostic criteria for major depression, at the same 
level (moderate) as before treatment started. These considerations indicate that for CBT anti-
depressive treatment trials, even minor differences in statistical effect sizes equates to a 
clinical meaningful change.  
 
Specific moderators for treatment outcome (effect size) 
Effect sizes may vary according to the characteristics of the included studies, their 
samples (clients) or the setting of the studies. As such differences may influence treatment 
outcome (quantified as effect sizes) it is considered highly informative to investigate if any 
specific variables have an undue, or confounding, effect on the outcome of a psychotherapy 
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trial.  These variables, often denoted as moderators, typically consists of easily identified 
characteristics that are reasonably unproblematic to categorize. For clients entering a trial 
investigating the effect of psychotherapy for depression, the following variables are typically 
registered and investigated; gender, age, degree of psychiatric comorbidity, use of 
psychotropic medication and severity of depression. Previous studies have typically not 
revealed any significant differences in treatment effects related to gender and age 
(Joutsenniemi et al., 2012; Wierzbicki & Pekarik, 1993), while a higher degree of psychiatric 
comorbidity often implies a worse course of illness or treatment prognosis. The most common 
Axis I comorbidity is anxiety disorders (Kessler, et al., 2003), which usually imply a higher 
degree of severity at intake (Kohler et al, 2013), as well as a poorer natural course (Penninx, 
et al., 2011). The presence of comorbid Axis-II disorders, of which the Cluster C diagnoses, 
particularly, avoidant personality disorder, are the most prevalent (Friborg et al, 2014), 
heightens the risk of a worse outcome following treatment (Newton-Howes, Tyrer, & 
Johnson, 2006). The relative efficacy of psychotropic medication versus CBT has been 
subjected to many clinical trials; however, a meta-analysis of 21 studies found no differences 
between the two treatment modalities in alleviating depression (Roshanaei-Moghaddam et al., 
2011). The addition of medication to CBT has been studied to a lesser degree; however, a 
meta-analysis consisting of seven studies found that CBT plus medication was slightly better 
(d = 0.32) than CBT alone (Cuijpers et al, 2009). With regard to the severity of depression, 
previous research has found that patients who were more severely depressed, reported larger 
treatment effects than less severely depressed patients. This phenomenon is also described as 
regression to the mean (Garfield, 1986; Lambert, 2001).  
For characteristics related to the therapist, the variables most typically investigated are 
type of therapist (psychologist, psychiatrist, general practitioner, student, etc.), and ratings of 
the competence of the therapist. Previous research has not indicated any significant difference 
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related to type of therapist, although more therapeutic experience has been found to relate to a 
shorter time to remission (Okiishi et al., 2006).  
When it comes to trials investigating CBT as an anti-depressive treatment, the 
technique-specific and methodological factors investigated typically consists of number of 
therapy sessions, application of a CBT manual (typically Beck`s original manual from 1979), 
and checks of adherence to the treatment protocol (including subsequent feedback to the 
therapists). A dose-response relationship has been documented, in that additional sessions of 
therapy usually lead to a higher treatment efficacy (e.g., Howard et al., 1986). Adherence to a 
treatment manual, which ensures correct implementation of CBT, has been found to improve 
the outcome (Shafran et al, 2009). 
Common methodological moderators for psychotherapy trials in general, are type of 
statistical analyses (intention to treat or completers), and ratings of the methodological quality 
of the study. Studies using stricter criteria for methodological quality generally yield lower 
treatment effects (Gould, Coulson, & Howard, 2012). A quite recent meta-analysis (Hans & 
Hiller, 2013) showed slightly larger effect sizes in depression treatment trials using a 
statistical design requiring treatment completion (d = 1.13), as compared to an intention to 
treat (ITT) design (d = 1.06).  
When it comes to the general surroundings and environment of any trial (the common 
factors), there has not been a great deal of systematic investigation, except for perhaps ratings 
of therapeutic alliance. Patients experiencing a stronger alliance with their therapist have been 
reported to show better effects of their treatment (Rector, Zuroff, David, & Zindel, 1999). 
Researcher allegiance has increasingly received attention as a potential factor that 
could significantly moderate the reported effect sizes in randomized controlled trials, and, as 
such, also in meta-analyses. However, historically there are very few RCTs in which the 
researchers disclose their allegiance. A recent and comprehensive study investigated how 
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many authors of RCTs in the field of psychotherapy reveal their allegiance (Dragioti et al, 
2015). The results showed that from 793 trials where obvious researcher allegiance was 
found, only three percent of authors stated their allegiance in the article text itself. This 
finding does have a large bearing on meta-analyses in the next instance, where only 17 
percent of 146 papers included information about allegiance. Further, only four percent of 
meta-analyses employed a proper method to control the effects of allegiance in the individual 
trials. The meta-analyses comprising the current thesis do not investigate or report researcher 
allegiance, and the lack of relevant information in the individual trials are the main 
explanation behind this choice.  
Another common factor for trials may be country, or region, for where the trial is 
investigated. A recent meta-analysis found no differences in ES for studies performed in the 
US vs the rest of the world (Christea et al, 2017). From a wider perspective, common factors 
could also consist of type of political system, religious views, and other cultural and societal 
characteristics. The influence these variables may have on treatment effects have not, to the 
best of the doctoral candidate`s knowledge, been previously systematically investigated. 
 
 The underpinning of effect sizes 
When a treatment is efficacious, psychotherapy research trials point to four sources to 
explain the observed improvements: (1) client factors, (2) therapist factors, (3) the so-called 
common factors, and finally, (4) technique-specific factors. Client factors represent the 
characteristics of the patient, such as personality traits, temperament, motivation for 
treatment, or important life events experienced by the patient during the course of therapy.  
Therapist factors are the characteristics of the therapist, which can include anything from 
gender, age, and education to personal style and appearance. Clinical training, competency, 
and skills in establishing a therapeutic alliance and using therapeutic techniques are of 
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particular importance (Crits-Cristoph, 1991). The two latter components may also be denoted 
as common and technique-specific therapy factors, which influence the outcome of CBT. 
The common factors represent characteristics of the treatment setting that are 
important and common to all therapy models. These characteristics may include the context of 
therapy; the client, the therapist, and their relationship (usually coined as the therapeutic 
alliance); how expectancies for improvement develop; a plausible rationale explaining the 
patient's illness; or even therapeutic techniques that are not specific to a therapy model.  
The technique-specific therapy factors represent those elements that are specific to a 
particular therapy model, and typically are described thoroughly in therapy manuals, 
indicating specific topics to be addressed during therapy, how they should be conveyed, the 
implementation of structure, the number of therapy sessions, the degree of exposure, and/or 
the schedule of homework tasks.  
The use of experimental designs has been the choice of researchers when it comes to 
providing insight regarding which of the four variance components contribute most to the 
treatment effect. Such procedures are an attempt to isolate and define the influence of the 
different factors, to identify which ones are the most important to improve. Previous studies 
have shown that a major part of the treatment effect seems to be caused by the client-related 
and common factors, which explain between 30–40% and 30–50% of the total treatment 
effect, respectively (e.g., Horvath & Greenberg, 1986; Luborsky et al., 1988). The therapist-
related factors have been found to explain 5–15% of the treatment outcomes (Huppert et al., 
2001; Wampold & Brown, 2005). Such calculations leave approximately 10–20% of the 
effect attributable to the specific therapy (Lambert, 1992; Duncan, Miller, & Sparks, 2004).  
Since the common factors have been shown to be so important for attaining 
improvement following therapy, psychotherapy researchers have increasingly become 
concerned how to integrate them into the therapy (Imel & Wampold, 2008). An important line 
45 
 
of support for the common factors model comes from meta-analyses showing that different 
treatment modalities produce relatively comparable treatment effects (e.g., Smith & Glass, 
1977; Wampold et al. 1997); hence, the assumption that elements common to all therapies 
underlie the lack of marked differences among them (Lambert & Bergin, 1994; Seligman, 
1995). The most important ingredient in the common factors have been the working alliance 
between the therapist and the patient. A more solid alliance is associated with quicker and 
larger treatment effects (Rector, Zuroff, David, & Zindel, 1999), and a reduction in the 
number of early dropouts (Kegel & Fluckiger, 2014). 
Therapists who use CBT are trained to establish rapport by, for example, socializing 
the patient to the cognitive therapy process (thus, being explicit about how the therapy will 
progress, which may reduce uncertainty), communicating to the patient how CBT might be 
helpful (instilling hope and positive expectations), and educating the patient about the 
disorder per se (helping patients to understand their problems). Moreover, CBT therapists set 
an agenda in collaboration with the patient in order to avoid spending the limited amount of 
time they have on irrelevant topics. They actively invite the patient to provide feedback, to 
ensure a mutual understanding and provide opportunities for quick adjustments. They 
construct and continuously refine their conceptualization of the case, further facilitating and 
deepening the understanding of the patient’s problems. They collaborate actively with the 
patient in making plans for between-session tasks that may help eliminate negative personal 
beliefs and behaviors. The latter may help the patient to attribute positive changes to their 
own efforts, thereby increasing self-efficacy. For this reason, improvements in self-efficacy 
may be mediated by using specific techniques aimed at improving self-efficacy, in addition to 





A modern holistic approach 
As the common factors are universally recognized as having the largest influence on 
treatment effects, a further investigation of their true constituents is warranted. The 
framework of the common factors is our immediate world; the “here and now” for every 
citizen on planet earth. The main elements in this frame are society, culture, geographical 
position, political state, technological advances, school systems and environmental 
developments. Attitudes, and ethical, ideological, philosophical, and religious views are also 
higher-order common factors. Moving down the hierarchy, we observe the background, 
upbringing, and immediate environment of each client (and therapist), as well as their 
neighborhood, class of school and workplace. Even further down the line, we find the 
common factors that previous research has identified as contributing to treatment effects, such 
as the context of therapy, expectancies, the placebo-effect, and the working alliance.  
Every specific treatment, like CBT, has come to life in a specific set of common 
factors, represented by the leading ideas and views present in the society of the therapy`s 
conception. The influences of the common-factors also have their bearing on client and 
therapist-factors. Both parties are embedded in, and influenced by, the context of their own, 
specific environment. It is thus essential to keep in mind that also every specific factor 
(technique or treatment form) is embedded within the larger framework of the common 
factors. This notion suggests that there is a hugely complex, advanced, dynamic and 
continuously developing interaction between what has been previously coined as the common 
factors, and the other factors (client, therapist and technique). They are inextricably and 
inherently connected to each other. If there is development on one part, there will invariably 
be effects for one (or more) of the other.  
Previous research has provided examples of the interaction between factors related to 
treatment effects. The role of specific versus non-specific factors in CBT seem to shift with 
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the provision of an increasing number of therapy sessions (Honyashiki et al, 2014). 
Intuitively, this makes sense, as (the lower order) common factors (e.g., alliance) should be 
more important in the beginning of therapy, while efficient implementation of treatment-
specific factors is increasingly important as therapy progresses – and gains more effectivity by 
having a solid foundation from the start. In addition, the role of common factors has also been 
shown to depend on the mental disorder of the patient. For example, patients with borderline 
personality disorder may respond much more favorably to the relationship and alliance-
building skills of a therapist (Bienenfeld, 2007) compared with patients with bipolar 
disorders. These are but two minor examples of the interaction between common factors and 
specific factors. However, in the treatment room the factors are always and inevitably linked 
in various and complex manners. This also holds true for the valued and important working-
alliance between patient and therapist. The alliance is also highly influenced and determined 
by the overriding factors, consisting of culture, attitudes, ideas, general knowledge, and 
background on each parts behalf. 
When it comes specifically to CBT as a depression treatment, we have an intervention 
(technique, specific factor) developed in the United States (US) of the 1970`s (common 
factor; society, geography, knowledge etc.), delivered by therapists in all shapes and forms, to 
an even larger variation of patients (therapist, client-factors), throughout the passing of more 
than 40 years of time. As specific techniques dictated by a therapy model, according to the 
current understanding, represent a small part of the overall treatment effect, one would 
theoretically expect that refinements or improvements of CBT approaches over the past 40 
years would have little impact on treatment efficacy, or reported effect sizes. This lack of 
impact would be even more pronounced for therapy that adheres to the original CBT-manual. 
However, it is at this junction it becomes essential to keep in mind that the implementation of 
any specific treatment component is always embedded within a common factors model. This 
48 
 
interaction strongly implies that it is entirely plausible, and expected, to observe significant 
changes in treatment effects with the passing of time – even (and perhaps more so) if the 
technique remains unchanged. In fact, the opposite view implies a bizarre scenario: For no 
development in treatment effects to occur, the world would essentially have to stand still, with 
every aspect of life being the same – as the years pass on. This especially holds true the longer 
a treatment paradigm, or technique, is in existence. 
 
Temporal developments and time-trends 
 A hallmark of our modern society has been the rapid development in many domains, 
particularly in science, technology, and health. Old procedures and methods have been 
replaced with safer and more effective solutions. For example, in somatic health care, cruciate 
ligament surgery currently takes considerably less time, requires fewer resources, and has a 
better long-term prognosis than it did 30 years ago (Cirstoiu et al., 2011). Another example is 
a percutaneous coronary intervention (formerly known as coronary angioplasty), which uses a 
catheterization technique to insert a stent in the groin or arm to improve blood flow in the 
heart’s arteries. The technique is quick and presently requires minimal rehabilitation (an 
overnight hospital stay); hence, it represents a huge improvement compared to older 
techniques (Knapik, 2012). 
Despite the large number of clinical trials and reviews of both CBT and other forms of 
therapy, the author of this thesis did not find any previous publications or attempts made to 
systematically evaluate how the efficacy or effectiveness of CBT has evolved over time. The 
publication of paper I in this thesis did, however, ignite activity in this area of research. The 
subsequently published, relevant studies will be evaluated and critically reviewed in the 
discussion part of the present thesis. 
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The reasons why researchers have not previously focused on temporal developments 
of treatment effects are largely unknown. One factor probably relates to methodological 
challenges. Comparable improvements/developments in somatic healthcare are clearly 
defined and have standardized procedures, with the outcomes being more readily observable. 
Another likely issue relates to statistics. Having knowledge of, and access to, the right 
analytical tools is imperious for any complex calculation of effect sizes and its potential 
moderators. A third factor probably lies within the attitude of clinicians and researchers; “if it 
isn’t broke, why fix it”, the notion being that it is not worth investing time and effort into 
scrutinizing a seemingly highly functioning and effective treatment. After all, any therapy that 
still exists after 5 decades, is obviously not ineffective. And the clinical form of “natural 
selection” (RCTs) would probably sooner or later get rid of the ineffective approaches 
anyway. However, when considering the vast number of patients worldwide afflicted by 
depression, even the smallest loss or gain in treatment effects would translate into huge 
numbers when it comes to overall monetary and health wise considerations. 
 
Aims and hypotheses 
 Paper 1 
The first article, “The effects of Cognitive Behavioral Therapy (CBT) as an anti-
depressive treatment is falling: A meta-analysis” offers a meta-analytical examination of 
treatment effects and effect sizes connected to individual CBT.  The primary objective and 
aim was to examine whether published clinical CBT trials aimed at treating unipolar DDs 
demonstrate a historical change in treatment effects. The secondary purpose was to examine 
the role of various moderators of the reported effect sizes. Further, in order to examine if the 
client, therapist, technique, and common factors were related to treatment effects differently 
across time, all of the available data related to these components in the CBT studies were 
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included in the meta-analysis. Finally, an examination as to whether these moderators 
influenced the regression slopes describing the time trends in the treatment effects was 
performed.  
The hypotheses were set a priori and based on knowledge available at that time (2014). 
The assumption was that although CBT treatments have focused less on the common factors, 
it was still deemed plausible that CBT therapists had become increasingly aware of the 
importance of integrating common and specific techniques to take full advantage of the 
therapy. Therefore, the expectancy was for contemporary CBT treatments to show better 
treatment outcomes when compared to older clinical trials. It was also predicted that 
diagnostic severity and type of therapist (psychologist or student therapist), and therapist 
competency would be associated with better treatment effects, while the variables age and 
gender were not expected to co-vary with therapeutic outcome. 
 
Paper II 
 The second article in this thesis, “The effect of cognitive behavioral therapy as an anti-
depressive treatment is falling: Reply to Ljottson et al (2017) and Cristea et al (2017)”, was 
both an extension of the analyses made for paper I, as well as a critical reassessment of two 
subsequent studies challenging its original results and conclusions. This paper`s primary 
objective and aim was to reanalyze the data set for nonlinear time trends, examining the 
conclusion from Ljottson et al, where they stated that the drop in effect sizes for CBT had 
been halted from 2001 and onwards. The secondary purpose of this article was to examine 
and critically assess and evaluate the findings and conclusion from the meta-analysis 
performed by Cristea et al (2017), where the authors essentially denied the existence of a true 
drop in treatment effects with time for CBT. The expectancy was to achieve a more nuanced 
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explanation of their findings. The hypothesis was that the reanalysis would affirm the original 
findings from paper I. 
 
Paper III 
 The third article, “A meta-analysis of group cognitive behavioral therapy as an anti-
depressive treatment: Are we getting better?” followed in the footsteps of paper I and used a 
similar approach to investigate the temporal developments of treatment effects for GCBT. The 
study had an exploratory design, and no hypotheses were thus set in advance. The aim was to 
examine whether there was a similar decline in effect sizes of GCBT for depression with 
advancing publication year, as was observed for individual CBT. A second purpose was to 
investigate moderators of the reported effect sizes of GCBT. As meta-analyses are considered 
the best available method for such evaluations, as well as for examining time-trends, this was 
again the preferred statistical choice. The rationale for paper III was thus to provide 
information and updates with regards to the development of effect sizes for group cognitive 
behavioral therapy over time. 
 
 Paper IV 
 The fourth article, “Time trends in the effects of mindfulness-based cognitive therapy 
for depression: A meta-analysis”, followed in the footsteps of the previous articles, with its 
focus on CBT-related treatment and time-trends. This time the aim was to investigate ESs and 
explore if there were any significant time-trends related to a modern development of CBT, the 
mindfulness-based cognitive behavioral therapy. The main interest concerned if a form of 
therapy with a much shorter lifespan, 10 years for the included papers in the meta-analysis, 
also would show a decrease or increase in treatment effects with time. Potential moderators` 
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influence on effect sizes were also investigated. As the article covered previously unchartered 
territory, the design was exploratory, with no specific hypothesis set in advance. 
 
General aims and hypotheses for the thesis 
 The main aim of this thesis was to examine whether any changes in CBT`s effects as 
an anti-depressive treatment have taken place since the introduction of this form of therapy 
five decades ago. Contemporary cognitive behavioral therapy is found in varying designs and 
formats, all of which share the basic cognitive assumptions and theoretical framework. As 
such, the time-trends for individual CBT, group CBT, and mindfulness-based CBT were all 
investigated in separate analyses and papers, with a common meta-analytical design. The 
secondary objective was to investigate potential moderators of effect sizes and time-trends. 
Subsequently, data for selected variables were registered and analyzed in subgroup conditions 
for all meta-analyses.  
Broadly speaking, the designs of the meta-analyses were exploratory. This is because 
a limited amount of research and knowledge regarding time-trends existed prior to the 
publication of the articles comprising this thesis. However, the initial hypothesis was that 
CBT as a treatment for depression would show an improvement with time.  
 
Methods 
 The present thesis comprises work from three different, but thematically linked 
projects. The first two papers utilized identical sample and data set, while papers III and IV 
have separate datasets. All papers incorporated a similar meta-analytical approach and design, 
in which individual trials were systematically searched for, and their results collapsed and 
summarized through meta-regression analyses.  
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 Although the current section provides a description of methodical aspects, information 
is kept at a level deemed appropriate for summarizing purposes. For a complete and detailed 
description and overview of all methodical aspects, flow-charts, figures, and tables, please 
observe the relevant sections in the original and published manuscripts for the individual 
studies. As the proposition of a thesis provides an arena to expand the rationale behind 
selected methodical choices, relevant parts of the current section provide a more detailed 
insight in the decision process as compared to the original articles. 
 
Individual CBT (Paper I)  
Data collection, studies & selection criteria 
A thorough search procedure was conducted in January 2015. Following a review of 
relevant abstracts, 489 articles were obtained via the University library. The following 
exclusion criteria were then applied: (1) the implemented therapy was not pure cognitive 
behavioral therapy. Among the studies comparing CBT with other treatment forms 
(interpersonal therapy, for instance), we included only the CBT treatment arm; (2) a unipolar 
DD (either mild, moderate, severe, or recurrent) was not the primary psychiatric diagnosis; (3) 
participants were not adults (mean age < 18); (4) therapy was not implemented by a therapist 
trained in CBT; (5) the psychotherapeutic intervention was not intended to treat depression; 
(6) the outcome was not measured with the BDI or the HRSD; (7) patients had acute physical 
illnesses or suffered from bipolar or psychotic disorders; (8) treatment was not implemented 
as individual face-to face therapy; and (9) the patients had a BDI score lower than 13.5. If a 
study assigned patients to different sub-groups based on diagnostic severity (usually based on 
the pre-test BDI scores), only the most severe sub-group was included to avoid inflating the 




Coding of study information and moderator variables 
The following data from the studies were coded: demographic information (gender and 
age), year of implementation of the intervention, duration (number of sessions), type of 
therapist (psychologist, trained psychology-student, or other/unknown), therapist competence 
(as measured by the Cognitive Therapy Scale), information about the severity of the diagnosis 
(mild, moderate, severe, or recurrent depression) along with the proportion (%) of the sample 
having comorbid psychiatric diagnoses, whether the patient population had any special 
characteristics, and the proportion (%) of patients using psychotropic medication.  
We investigated whether the effect sizes co-varied with any of the following 
moderator variables: type of statistical analysis (intention-to-treat versus completers analysis), 
gender (as % men), age, proportion of patients using medication, proportion of comorbidity, 
use of the Beck CBT treatment manual versus no manual, checks (and subsequent feedback) 
of therapist adherence to the treatment manual, version of BDI (I or II), severity of the 
depressive disorder, diversity of the study populations, number of therapy sessions, type of 
therapist, therapist competency, and the publication year of the CBT intervention (the 
moderator of most interest). We also examined whether the latter variable co-varied with the 
effect sizes in the waiting list control groups. The competence of the therapist was, in a few 
studies, rated using the Cognitive Therapy Scale (CTS; Dobson et al, 1985), and it was 
included as a moderator. The Randomized Controlled Trial Psychotherapy Quality Rating 
Scale (RCT-PQRS) was used to rate the methodological quality of the published studies 
(Kocsis et al., 2010).  
 
Effect sizes & statistical calculations 
We used two procedures when calculating the effect sizes based on the BDI and the 
HRSD pre-/post-intervention scores: a pre-post within-study design, and a controlled trial 
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(CT) design. For studies that did not include a no-intervention control group, a standardized 
mean difference (SMD, or Cohen`s d) was calculated for the intervention group. A Hedges g 
correction was then applied to the SMD.  
The effect sizes for the treatment remission rates were coded as an event rate (rate = 
number of patients achieving remission/sample size). Remissions were, by the authors of the 
individual studies, deemed to have occurred for patients who ended treatment with a BDI 
score below a pre-defined clinical cut-off score, < 10. This is in accordance with common 
interpretations of the BDI, where scores from 9 and below are considered to be under the 
clinical threshold for a depression diagnosis. 
The Comprehensive Meta-Analysis software, version 2 (Borenstein et al., 2005) was 
used for all statistical analyses, except for the two-way interaction analyses between the 
moderator variables, which had to be analyzed in SPSS 21. Meta-regression analyses were 
used to analyze the role of the continuous moderator variables (e.g., publication year), and 
were based on the unrestricted maximum-likelihood method, as it assumes an underlying 
random distribution of effect sizes. The moderator analyses for the categorical variables were 
based on a similar Q-test statistic to examine whether the variability between categories 
(subgroups in the study) was larger than the variability within studies. The influence of the 
time variable on ES was examined based on both the BDI and the HDRS, in addition to the 
remission rates. The associations of the other moderator variables and ES were examined 
based on the BDI measure, which had the largest number of studies. 
 
Publication bias and heterogeneity 
Heterogeneity was calculated as I². This is an intuitive and simple expression of the 
inconsistency of the studies’ results (Higgins et al., 2003). To identify any publication bias or 
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undue outliers, visual inspections of the funnel and forest plots were performed, and Duval 
and Tweedie`s trim and fill method was used. 
 
A non-linear re-analysis (Paper II) 
 In addition to encompassing a broad theoretical discussion of the findings in paper I, 
this study consists of additional statistical analyses performed on the same dataset as paper I. 
For analyses regarding the BDI, we first visually inspected the scattering of the 
weighted ESs in the regression line and noticed that the decline was fairly stable until the year 
2001. Moreover, the reported ESs between the years 2001 and 2014 seemed slightly inverse 
u-curved rather than completely flat, as the piecewise model suggests. To examine this 
possibility, we specified a segmented model consisting of two parts: a linear part describing 
the whole time period (1977-2014) and a quadratic part describing the time trend following 
the breakpoint.  The breakpoint was empirically chosen by searching for the publication year 
that could render both parts of the model to be statistically significant. This only happened if 
publication year was centered at the year 2001. The nonlinear model also yielded the highest 
model fit in terms of the R-square index.  
For the HDRS, the nonlinear model (similar as above), which fit best when centered at 
the year 2001 (R2 =.298), was not better than the best piecewise model centered at 1998 (R2 








Group CBT (Paper III) 
 The design and procedure for this article was similar to paper I. However, some 
methodological and statistical adjustments were made in order to further improve the 
reliability and validity of the results. The relevant adjustments are reported in the following 
sections. 
 
 Data collection & selection criteria 
 All Search queries returned 26,479 studies. By examining their titles, the abstracts of 
934 papers were read by the first author to judge their relevance. Following that review, 181 
papers were obtained from the university library. The same exclusion criteria as for paper I 
were then implemented, except now the delivered therapy had to be GCBT, and the included 
trials had to be randomized controlled trials (RCT`s). The selection procedure was conducted 
by the first author and yielded a final study pool of 37 papers. 
 
Coding of study information and moderator variables 
The following data were coded from the papers: demographic information (gender and 
age), year of implementation of the intervention, country in which the intervention took place 
(U.S. vs. the world), duration of treatment (number of sessions), type of therapist 
(psychologist or trained student), and information about the severity of the diagnosis (mild, 
moderate, severe, or recurrent depression). The depression diagnoses of the patients were set 
according to the original authors’ definitions. If unreported, we categorized the diagnoses 
based on the BDI pre-scores as mild (13–19.5), moderate (20–29.5), or severe (>30). The 
moderator “manual” was coded dichotomously, according to whether a set manual was 
followed or not.). Effect sizes were examined as to whether they co-varied with any of the 
moderator variables listed above. As the number of trials using HDRS-scores was low, no 
58 
 
sub-group analyses were performed for this outcome measure.  The RCT-PQRS was used to 
rate the methodological quality of the published studies. Coding of all variables was 
completed by the first author. 
 
 Effect sizes and statistical calculations 
For the first analysis, which included all 35 RCTs using the BDI, a standardized mean 
difference (SMD, or Cohen’s d) was calculated for the intervention group (Mpre–Mpost, 
divided by the standard deviation of the change score). A Hedge’s g correction was applied to 
the SMD. All interventions consisted of GCBT that used a RCT design.  
For the second analysis, which consisted of the 16 RCTs that included a no-treatment 
control group, the effect sizes were calculated from the difference between pre- and 
postscores on the BDI for the GCBT group and the no-intervention group, respectively, and 
then standardized using the change scores. For the third analysis, the same procedure as for 
the first analysis was used (a within-study design), but this time the outcome measure was the 
HDRS. 
Although all studies in the present meta-analysis were originally randomized 
controlled trials (RCT), several of the RCT studies only included other treatment comparison 
groups (e.g., another psychotherapy group or medication treatment arm), and hence did not 
include a no-treatment control group (e.g., a wait-list group). These studies were coded as 
within-study designs. The remaining studies, which included a no-treatment control group, 
were thus coded as controlled trials in our analysis. In addition, these studies were also coded 
as within-studies and added to the separate within-study design pool. Thus, the two statistical 





Mindfulness-based CBT (Paper IV) 
 Design and procedure 
 This paper largely followed the templates from paper I and paper III. It had an 
exploratory meta-analytic design, with a focus on identifying time-trends with relevance to 
effect sizes. A systematic search was conducted in 2018. The following inclusion criteria were 
applied: 1) MBCT was given in a group format aimed at reducing depression; 2) participants 
were adults (≥ 18 years of age) diagnosed with depression or showing elevated scores on the 
BDI (> 13) or the HDRS (> 8), as a group; 3) a version of the BDI or the HDRS was used as 
an outcome measure; and 4) publication was in English and was in a peer-reviewed journal.  
Studies were excluded when 1) MBIs other than MBCT were examined, 2) no 
treatment effects for MBCT were investigated or reported, 3) depression was not the principal 
problem of the participants; 4) partial or complete sample overlap with a study already 
included in the meta-analysis was observed, 5) information necessary to calculate ES (i.e., 
means and standard deviations) was lacking, or 6) only dichotomous outcomes (e.g., relapse) 
were reported. 
 
Moderator variables & coding 
For each study included in the meta-analysis, the following information was extracted: 
1) year of publication; 2) sample size of the MBCT group and the control group; 3) mean age 
and percentage of females in the MBCT group; 4) number of sessions; 5) modification of the 
treatment manual by Segal et al. (2002; 2013); 6) use of the BDI or BDI-II as outcome 
measure; 7) no treatment vs. active treatment comparison groups; 8) randomization of 
participants; and 9) reporting results of intent-to-treat (ITT) analyses. For the meta-analytic 
calculations, means and standard deviations of the BDI and/or the HDRS at pre-treatment and 
post-treatment were extracted for the treatment group and, if present, for the control group(s). 
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To assess the methodological quality of the studies included in the meta-analysis, the Jadad 
scale (Jadad et al., 1996) was used. 
 
Effect sizes & statistical calculations 
To obtain the ES for each study, the SMD between the intervention group and control 
group, and/or the pretest and the posttest was calculated correcting for bias (Hedges' g). This 
procedure is intended to prevent the inflation of small samples` effect size, but visual 
inspections of the funnel plots revealed that one study in the within-group pre-post score 
design (Alboghasemi et al, 2015) had much larger ESs as compared to all the others studies, 
across statistical conditions. However, the funnel and forest plots did not seem to indicate 
large skewness, so the decision was made to include the trial in the specific analysis.  
The analyses were conducted separately for controlled studies (between-group) with 
and without active treatment comparisons and pre-post differences (within-group) and for the 
BDI/BDI-II and HDRS as outcome measures. When data for ITT samples were available, 
these were preferred over data from completer samples. This choice reflects a methodological 
shift over time for treatment trials and RCTs, in the sense that ITT scores are more likely to be 
reported than scores based on completers in contemporary studies. To examine publication 
year as moderator for the pooled ES, a meta-regression analysis was used. 
 
Ethical considerations 
 As papers I – IV in the present thesis consisted of summarizing and analyzing the data 
and results from previously published articles in recognized journals, no specific ethical 
considerations were deemed necessary. Caution were being made for interpreting and 
communicating the findings in an objective and prudent manner, while still maintaining a 
distinct and informative presentation of the results. 
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Summary of papers 
 The current summary presents and discusses the results for the individual studies in a 
prudent and pragmatic manner. For a detailed observation and discussion of all results, 
statistics, tables, and figures, please observe the relevant sections in the original and published 
manuscripts for the individual articles.  
 
Paper I: The effect of cognitive behavioral therapy as an anti-depressive treatment is falling: 
A meta-analysis. 
 Results 
 The average weighted effect size for the BDI (k = 67) was g = 1.58 (CI.95 = 1.43 to 
1.74). For the HDRS (k = 34), the average ES was 1.69 (CI.95 = 1.48 to 1.89).  
The CBT effect sizes based on the BDI had a significant negative relationship with 
time, i.e., publication year (p < .001). According to a sub-group analysis, a similar negative 
relationship was evident among studies using within-group designs (p < .001), and controlled 
trial (CT) designs (p < .05). Please observe figure 1. 
The effect sizes for the HDRS showed a comparable picture, as ES decreased with 
time (p = .01). See figure 2. The significant negative relationship was evident for the within-
group design studies (p < .01). The ES in the CT studies also showed a declining direction, 
but it was not significant (p = .51). The remission rates (defined according to percentage of 
patients achieving sub-clinical levels of symptoms, as measured by the BDI) were negatively 
related with publication year (p < .01). 
Several extensive subgroup-analyses confirmed the main finding of a decrease in 
effect sizes with time, while, in contrast, the waiting list control group condition exhibited no 
significant changes in effect sizes across time (p = .48). 
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Publication bias for ESs was thoroughly investigated, leaving the conclusion that there 
did not exist any undue effects to the time-trend results. 
A separate analysis for each moderator variable was conducted. For client-related 
variables, the moderator gender variable was significant (p < .05). Studies that included a 
higher percentage of women demonstrated a better treatment effect than studies consisting of 
more men. 
For therapist-related variables, the effect size differences between types of therapists 
were significant (p < .01), indicating that trained psychologists achieved better treatment 
effects (g = 1.59) than did psychology students (g = 0.98). 
The weighted correlation coefficients between time (publication year) and the 
moderator variables showed the following statistically significant relationships: Pre-
intervention score BDI (r = .26, p = .04), severity (mild-moderate-severe) of depression (r = -
.04, p = .78), methodological quality (r = .43, p < .001), and BDI (I vs. II) version (r = .59, p 
< .001). These analyses indicate that the methodological quality has improved significantly 
over the years. Newer trials also include more patients with higher initial BDI scores as 
compared to the older trials. None of the other moderators specified in the “methods” section 
showed a statistically significant result. 
Finally, we examined whether the observed decline in the treatment effects depended 
on any of the investigated moderators by conducting two-way interaction tests (time × 
moderator). None of the moderators showed a significant interaction effect. Although the 
moderator “manual use” was not significant, it is interesting to note that studies using the 




Figure 1. The plot portrays the negative change (p < .001) in BDI effect sizes across time (k = 
61). The size of the circles indicates the relative contribution (random weight) of each study 









Figure 2. The plot portrays the negative change (p < .01) in HDRS effect sizes across time (k 
= 34). The size of the circles indicates the relative contribution (random weight) of each study 
to the analysis. 
 
Discussion 
The main finding was that the treatment effect of CBT showed a declining trend across 
time and across both measures of depression (the BDI and the HDRS). Contemporary clinical 
treatment trials for individual CBT therefore seem to be less effective than the therapies 
conducted decades ago. The declining effect of treatment over time seems robust.  
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We did not find evidence of significant differences in the treatment effects resulting 
from the use of the Beck manual (Beck et al, 1979) or not. However, the interaction analyses 
showed a slightly steeper decline for the CBT trials that used the manual compared to those 
that did not. This finding was rather surprising given that the original manual had a reputation 
among clinical researchers as one of the best ways to implement CBT. To the best of our 
knowledge, there have been no thorough investigations of how different ways of conducting 
CBT for depression may influence the outcome. Our findings indicate that further 
investigations regarding this matter are warranted. 
The major practical impact of this study would be to heighten the awareness among 
practitioners and clinical researchers of the trends in modern psychotherapy and stimulate 
research on the highly relevant topic of time-trends for effect sizes. If psychotherapy of today 
has a lower efficacy than that conducted 30 to 40 years ago, this threatens the validity of 
current comparative studies. If we compare the efficacy of a new psychotherapeutic approach 
with the current best standard, which, for example, may be CBT, we risk concluding that the 
newer approach is preferable even though it may have a weaker effect than the seminal CBT 
trials of the 1970s. Researchers conducting randomized placebo-controlled trials today, thus, 
risk implementing newer treatment approaches that are relatively better than the current best 
CBT. Yet, what is the benefit of doing so if the absolute change is minor or even negative 
compared to the seminal studies? 
 
Paper II: The effects of cognitive behavioral therapy as an anti-depressive treatment is 
falling: Reply to Ljòtsson et al. 
Results 
The analyses indicate that CBT treatment effects, as measured by the BDI, have fallen 
linearly from 1977 until 2001, and not until 1995 as proposed by Ljótsson et al. (2017). The 
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fall has been going on for about 24 years, which encompasses half of all studies (33 of 67). 
From 2001 onward, the treatment effects have not declined further, but stability in the effects 
cannot be claimed due to the significant segmented quadratic model. This model shows a 
temporary rise followed by another fall, which may or may not be ongoing. Whatever is true, 
the major point is that a flattening in the treatment effects of CBT, or that the CBT effects 
now vary around their “true” value, as Ljótsson et al. (2017) conclude, is not well supported 
by the available data. The segmented nonlinear model with the publication year 2001 as the 
breakpoint also explained 2.4% more of the variation in the treatment effects than the 
piecewise model with year 1995 as the breakpoint. 
Regarding the HDRS effects, the piecewise model did indeed fit the data best, as 
suggested by Ljótsson et al. 
 
Discussion 
The present reanalysis does not change the basic message stating that CBT effects 
have fallen considerably across two and half decades. In fact, the predicted ES for the year 
2014 even comes out slightly worse for the segmented nonlinear (g = 1.12), as compared to 
the linear, model (g = 1.18). Nevertheless, the current ESs are strong, hence CBT is still to be 
considered as an effective anti-depressive treatment. 
Since the current reanalysis shows that the nonlinear time trend explains a 
considerable portion of the between-study treatment variance (almost 30%), future meta-
analytic summaries of treatment effects should not dismiss potential time trends. 
To conclude, since the BDI effects during the last 13 years do not follow a flat trend 
but rather are in decline again, we believe a weather-climate analogy is an apt comparison: 
although weather varies across decades, the long-term climate changes (as projected by a 
linear model) may be regarded as the most reliable indicator. 
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Paper III: A meta-analysis of group cognitive-behavioral therapy as an anti-depressive 
treatment: Are we getting better? 
 Results: 
The average weighted BDI effect size for all studies, based on within ESs (k = 35), 
was g = 1.33 (CI.95 = 1.16 to 1.50. For the HDRS, using a within-group design (k= 14), g was 
1.56 (CI.95 = 1.20 to 1.90).  
For the first analysis (a within-study design), the GCBT effect sizes based on all 35 
RCT studies improved significantly with time as measured by the BDI (p = .02). See figure 3. 
For the second analysis (the between-group condition with the BDI as outcome measure), the 
ESs based on the 16 studies that included a no-intervention control group also improved 
significantly across time (p < .001). For the third analysis (a within-group design), effect sizes 
based on the 14 studies using the HDRS showed a non-significant trend towards a decline 
with the passage of time (p = .07, see figure 4). 
 Publication bias was inspected and deemed to be without any significant effect 
on the meta-regression line. Heterogeneity scores were in the moderate-to-high range for all 
analytic conditions, ranging from 46 to 84 percent. Separate moderator analyses were based 
on the BDI scores and revealed higher ESs for studies where no specific treatment manual 
was followed (p = .03). Further, additional analyses showed that for trials not using a manual, 
there was a significant improvement in ES with time (p < .01). This relationship between ES 
and time was not found for trials that used (or reported) a treatment manual.  
For the variable country, there was a tangible but non-significant tendency towards 
higher ESs for studies performed outside the U.S. compared to studies performed in the U.S. 
(p = .06, see Table 3). Separate follow-up analyses revealed that trials conducted exclusively 
in the U.S had a non-significant tendency towards improvement in ES with time (p = .06), 
while trials conducted in the rest of the world showed no signs of improvement with time. 
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Figure 3. The plot portrays the positive change (p < .02) in BDI effect sizes across time (k = 
35). The size of the circles indicates the relative contribution (random weight) of each study. 
 
Figure 4. The plot portrays the tendency (p < .07) in HDRS effect sizes across time (k = 14). 





The analysis showed a significant increase in effect size across time, as measured by 
Beck’s Depression Inventory. For the HDRS, the analysis did not confirm the findings of 
larger ESs with time. The discrepancy between the results from the two outcome measures 
was surprising, given the moderate to high correlation previously found between the BDI and 
the HDRS. Sub-group analyses and investigations over heterogeneity and potential bias were 
performed. The results suggested that the non-significant relationship between time and ES, 
as found in the initial HDRS-based analysis, were not as reliable as the significant relationship 
found by the BDI-based analyses.  
The present analysis found a negative relationship between the application of a 
treatment manual and outcome. Trials not following (or reporting) a manual had a 
significantly larger ES than those that did report use of a manual. This finding is consistent 
with a previous study that have found negative effects from the use of treatment manuals 
(Duncan & Miller, 2006). Furthermore, sub-group analyses showed that for trials where no 
manual had been used, there was an increase in treatment effect sizes with the passage of 
time. However, for trials using a treatment manual, there was no increase with time. This 
finding, not explained by differences in study quality, could be interpreted in several ways, 
but indications are that with regard to treatment efficacy for GCBT, the specific factors 
(techniques applied in treatment) do have a substantial bearing on treatment outcome; when 
following a set routine, treatment effects do not improve with time. The results of this analysis 
indicate that a shift in perspective should be considered regarding the most efficient way of 
implementing GCBT, as there seems to be a beneficial effect in varying and adapting the 
interventions, perhaps according to the patient group. The highly structured manuals could 




Paper IV: Time trends in the effects of mindfulness‐based cognitive therapy for depression: A 
meta‐analysis 
 Results 
The average weighted ES for between-group studies using a no-treatment control 
group and the BDI as an outcome measure (n = 11) was g = 0.92 (95% CI [0.70, 1.14], I2 = 
42.7). For the between-group studies using the HDRS and a no-treatment control group (n = 
7), the ES was g = 0.80 (95% CI [0.61, 0.99], I2 = 16.04). 
Analyses of time trends showed no significant relationships between year of 
publication and ES. 
None of the chosen moderator variables were found to moderate the observed ESs of 
between-group studies. For within-group comparisons using the BDI, sample size (b = 0.00, 
95% CI [-0.01, 0.00], p = 0.013), age (b = -0.08, 95% CI [-0.12, -0.03], p < .001), and 
baseline depression (b = - 0.04, 95% CI [0.01, 0.06], p < .01) were significant moderators. 
Thus, smaller sample size, lower mean age, and higher baseline depression wes associated 
with higher ESs. 
 
Discussion 
The results suggests that treatment outcomes were stable over time. It can only be 
speculated whether the reported ESs of MBCT for current depression already represent the 
upper limit of its effectiveness or whether factors such as insufficient therapist training and 
supervision (cf. Waltman et al., 2016) inhibit an increase of the effects. Another possible 
factor is that there simply has not yet been a large enough timespan to detect any significant 
trends related to time. 
A potential confounding factor could relate to the methodological choice of mixing 
scores from completers with scores from ITT. However, an inspection of the included studies` 
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plots revealed that the nine trials coded as ITT are evenly spread across the time range, and 
ESs did not seem to deviate from that of completers. Previous investigations have typically 
revealed rather small differences in effect sizes between ITT and completers. An extensive 
meta-analysis (Hans & Hiller, 2013) showed largely comparable effect sizes in depression 
treatment trials using a statistical design requiring treatment completion (d = 1.13), and those 
using an ITT design (d =1.06). This finding was replicated in a later study (Johnsen & 
Friborg, 2015), where no significant differences between ESs of completers vs ITT were 
found. Nor did a two-way interaction test (completers x ITT) reveal any significant impact on 
the developments of ESs with time. 
As to the overall effects of MBCT for acute depression, the results of the present study 
are consistent with previous meta-analytic studies (e.g., Lenz et al., 2016), suggesting that 
MBCT is effective in reducing symptoms of depression. Applying Cohen’s (1992) criteria, 
the average ESs for between-group studies comparing MBCT to no-treatment control 
conditions and pre-post studies were large for both outcome measures.  
 Based on the previous robust findings of the effectiveness of MBCT for current 
depression, it has been proposed that MBCT should be offered as a first-line treatment for 
depression on equal terms with other evidence-based treatments (Strauss et al., 2014). 
However, more research is needed to support this claim. It should be noted that the average 
ES observed for MBCT when compared to no treatment comparisons is lower than those for 
other psychological treatments. For example, for pre-post comparisons, the average ES for 
MBCT observed in the present study (g = 0.90) is smaller than those for individual and group 
CBT in clinical trials (g = 1.65 and g = 1.33, respectively; Johnsen & Friborg, 2015; Johnsen 






Comparing CBT, GCBT and MCBT 
 Effect sizes  
As the constituting meta-analyses in this thesis utilized identical ways of calculating 
effect sizes, comparisons across papers are allowed. When using a within-group calculation, 
the average ES for GCBT and individual CBT were comparable. Based on the HDRS, g was 
found to be 1.56 for GCBT and 1.69 for CBT. Average ES`s based on the BDI was 1.33 
(GCBT) and 1.65 (CBT) for the within-group format, and 1.14 (GCBT) versus 1.37 (CBT) 
utilizing a between-group design. The slight difference in effect sizes could partly be 
explained by somewhat larger pre-scores for patients entering trials with individual CBT. 
They averaged a score of 26.1, versus 24.2 on the BDI for patients in treatment with GCBT.  
The similarities in treatment outcome between CBT and GCBT highlights the question 
regarding which format of therapy to be prioritized in battling depression. Taking into 
consideration the beneficial cost-effectiveness of group therapy, this avenue deserves further 
investigation. Recent meta-analyses have shown that the monetary benefits involved in the 
application of group CBT does not seem to compromise treatment efficacy significantly, as 
the outcome differences between individual and group CBT trials are only slight to moderate 
(Hans & Hiller, 2013; Huntley et al., 2012). However, these reviews do not take into 
consideration the fact that group CBT seems to have increased in effect size over the years, 
while the opposite is found for individual CBT.  
Mindfulness-based CBT revealed somewhat smaller effect sizes, as compared to the 
more classical formats of CBT. For the BDI, the within-group and between-group conditions 
showed g = 0.90 and 0.92, respectively, while g based on the HDRS was 0.80. Although a 
firm conclusion would be hasty, there is little evidence to suggest this newer form of therapy 
is more effective as an anti-depressive treatment than its elder siblings. A more thorough 
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discussion on the topic of effect sizes and treatment outcomes follows in the section 
“explaining the results”. 
 
Moderator variables 
 The last couple of decades has generated a substantial amount of interest and research 
towards revealing the underpinnings of effective treatment. Such efforts have yielded a 
commonly accepted notion stating that there are four overriding factors contributing to ESs in 
psychological treatment. As these factors also could be significant for understanding temporal 
developments, a discussion of relevant findings associated with this thesis is considered 
informative. The four major factors consist of variables and characteristics linked with the 




When it comes to type of therapist as a moderator, the different analyses revealed 
different outcomes. For GCBT there was no difference in effects observed as a consequence 
of having a trained student therapist rather than a psychologist, but for individual CBT the 
results favored the more experienced psychologist. This relationship was not investigated for 
MCBT. Although these findings are interesting in themselves, there are no indications 
suggesting these results do have a moderating effect on the general time-trends regarding 
treatment effectiveness. This especially holds true as a two-way interaction test (Time x Type 
of therapist) for individual CBTs showed no relevant interaction effects. 
Another variable connected to the therapist-related factor, is the competency of the 
therapist. Unfortunately, very few studies rated or reported this moderator, preventing an 




The studies within this thesis collected and applied demographic information in their 
analyses. The only exception was for paper II, where of course the sample was the same as for 
paper I. Consistency was observed across studies, with the average age of the clients ranging 
from 39 years in the sample from paper IV, to 40.5 years in paper I. The proportion of men in 
the studies ranged from 24.3 to 40.2 percent. This is in accordance with general statistics 
revealing that significantly more women do indeed receive professional treatment for unipolar 
depression (WHO, 2020). Diagnostic severity, as measured by pre-treatment scores on the 
BDI, were also quite similar across the studies, ranging from 23.3 to 26.1. Thus, the 
distribution of age, gender and severity was largely comparable for clients entering trials for 
CBT, MCBT and GCBT across decades. 
 In concordance with previous research there were not observed any consistent or large 
effects related to the variables gender and age when it comes to moderating ES. For individual 
CBT, the analyses demonstrated that woman profited more from therapy than did men. This 
pattern was not evident for GCBT or MCBT. When examining the variable age, the meta-
analysis based on results from MBCT revealed that younger clients benefited more from 
therapy than did elder ones. This pattern was not observed for CBT or GCBT. 
For the moderator diagnostic severity, the study based on MBTC found that higher 
levels of baseline depression yielded larger ESs. A similar pattern was showed for CBT, were 
patients with milder levels of baseline depression tended to achieve lower ESs. For GCBT 
there was no such statistically significant result, although the data do indicate a potential 
difference in ES between mild depression (g = 1.18), versus severe depression (g = 1.38). The 
relatively low number of trials consisting of patients with higher rates of severity (k = 5) most 
likely limited the statistical power. 
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For individual CBT, paper I investigated whether levels of diagnostic comorbidity (for 
both physical illness and/or psychological disorders) and psychotropic medication affected 
treatment effects. The results showed no significant moderation of ESs. The paper also 
investigated correlations between the different moderators and time. Here, one significant 
correlation appeared, revealing that newer studies had higher severity levels on the BDI 
compared to older ones. As higher levels of severity are associated with larger ESs, it is 
interesting to observe that the fall in treatment effects with time show little sign of being 
halted. This is another robust evidence for a genuine fall in ES with time for individual CBT. 
The above findings are interesting in the broader scope of research on treatment 
effects, and some of the results could also provide valuable information when it comes to 
interpreting time-trends in treatment effects, as well as support the conclusions. This is 
discussed more thoroughly in the section “explaining the results”. However, for the main 
purpose of this thesis, the major factor of concern is whether any of the client-variables show 
an interaction-effect with time as a moderator. If that were the case, this would indicate 
systematic changes in the moderator itself (for example, more women entering therapy in later 
years than previous ones) being accountable for differences in ES as a consequence of time 
passing by. However, across all the included meta-analyses, such interactions did not appear. 
This leads to the conclusion that client related moderators generally do not exert any 
confounding influence on the temporal development of effect sizes. 
 
Common factors 
Perhaps surprisingly, there were very few studies that investigated or reported 
variables of interest related to the common factors. Even the variable working alliance, which 
has achieved a vast amount of attention for the last decades and is recognized as the most 
influential moderator for ES, lacked the necessary number of studies reporting a quantifiable 
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measure for any statistical comparison to be useful. This is a finding that points to the need 
for developing, and utilizing, a universally accepted scale for measuring the working alliance 
between therapist and client. Such a scale should aim to provide useful information that could 
aid both clinical and statistical purposes. There have been developments made in recent years, 
for example the working alliance inventory (Horvath & Greenberg, 1986). Still, these 
developments have yet to be translated into practice when it comes to clinical trials measuring 
the effects of anti-depressive treatment. 
Encompassing a broader perspective, study quality is also a common factor for 
published papers investigating treatment effects. For this moderator, perhaps surprisingly, 
none of the included meta-analyses found a significant impact on ESs caused by variations in 
study quality. For the MBCT-study, a likely explanation is the short timespan between studies 
(10 years), in which time it is implausible that large developments in study quality has 
occurred. The studies on CBT and GCBT showed a tendency indicating smaller ESs with 
better study quality, however, interaction-analyses featuring time vs effect size revealed no 
relationship of statistical significance. Summarized, the results do lend some support to the 
notion that better-quality studies achieve lower ES, although this effect is not very 
pronounced when it comes to CBT-based anti-depressive treatment trials. 
 
Technique-related 
As shown by the papers included in this thesis, cognitive behavioral therapy is 
considered and utilized as a short-term therapy for depression, with sessions typically ranging 
from 12 to 20 per treatment period. Within this range, none of the included meta-analyses 
found variations in treatment effects because of number of sessions provided. These findings 
support the use of CBT as a short-term therapy; it`s main effect is achieved regardless of 
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having 12 or 16 sessions, and the results do not indicate any increase (or decrease) in 
efficiency with extended sessions of therapy. 
The use of, and adherence to, a structured treatment manual, has been a major part of 
the foundations for CBT. The commonly accepted view in the field has been that diligently 
following a manual, and preferably the original manual developed by Beck, will yield the best 
outcome for the patients. This notion is heavily challenged by the findings from the analyses 
included in this thesis. For GCBT, there was a significant difference in ESs, favoring trials 
that did not use (or report) a set manual. For the meta-analysis investigating individual CBT 
there were no differences in overall effect sizes related to the use of the original Beck manual 
or not. For MBCT, all included trials were based on the original treatment manual. 
Summarized, the findings lend support to the notion stating that the use of a set manual is not 
doing effect sizes any favors when it comes to CBT-based treatment for depression. 
Closely connected to the variable “use of a manual”, adherence checks were reported 
to have been used by many individual CBT-trials. Although not explicitly investigated in our 
studies, indications are that the trials reporting ratings of adherence, are also those who use a 
set manual. The results of the analyses showed no differences in effect-sizes between trials 
utilizing adherence checks versus those who did not utilize such checks. This finding is thus 
in accordance with other results, suggesting that the use of a structured manual is not 
associated with higher ESs.  
 
Geographical differences 
One article in the present thesis investigated geographical differences. For GCBT, 
there was a trend approaching significance (p = .06) related to country of origin, with trials 
conducted outside the U.S. showing higher ESs. Follow-up sub-group analyses also showed 
that the ESs of studies conducted in the U.S. increased with time, a trend that was not evident 
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for trials conducted in the rest of the world. With time, studies performed in the U.S. have 
improved, reaching a present level of efficacy comparable to that of trials conducted in the 
rest of the world. This development is interesting, particularly when considering a similar, yet 
opposite, finding from another recent meta-analysis concerning individual CBT (Cristea et al., 
2017). In that study, ESs from studies performed in the U.S decreased with time, while ESs 
for trials from the rest of the world remained unchanged. However, the authors concluded that 
the observed effects most likely were spurious, mainly due to high levels of heterogeneity. 
Nevertheless, the common connotation for both CBT and GCBT seems to be that the largest 
temporal developments in treatment effects, regardless of direction, are limited to the U.S. 
One explanation for this finding could be that the range of publication years is larger for trials 
conducted in the U.S., thus increasing the potential for significant results to occur. Other 
explanatory factors are being discussed in the section “explaining the results”. 
 
Time-trends for treatment effects 
The common theme and main topic of investigation for this thesis and its associated 
meta-analyses and articles, was to discover, describe and explain relevant time trends in the 
treatment of depression, specifically for the different formats of cognitive behavioral therapy. 
Although the foundations are similar for individual CBT, group CBT and mindfulness-based 
CBT, the investigations revealed large variations in temporal developments and trends. For 
individual CBT there exists a robust and significant decline in ESs, while group CBT shows 
signs of improvement with time. For the newer mindfulness-based CBT, there is no 
development with time, as ESs have stayed at the same level since its inception. The 
completely flat regression line exhibited for MBCT is most likely due to two factors, one 
being the standardization of treatment as described earlier. The other contributor to the nil-
finding, is most likely the span of publication; all included studies were published between 
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2007 and 2017. This ten-year range represents a limited period for clear trends or tendencies 
to emerge.  
 
Clinical meaning of the results 
 The primary objective of the meta-analyses included in the current thesis was to 
investigate and explore the temporal development of treatment effects, quantified as statistical 
effect sizes. The secondary objective was to identify any potential moderating variables to the 
observed ESs, which could assist in explaining the results. However, the statistical and 
methodological considerations do not pinpoint the practical significance or clinical meaning, 
which are the factors of most interest for therapists and clinicians. It is therefore important to 
assess the clinical implications as closely as the available data allows. 
 First and foremost; the three anti-depressive treatments investigated in the meta-
analyses all enjoy a substantial treatment effect. CBT, GCBT, and MCBT will help patients 
get better from their depressive symptoms. However, the analyses also indicate that more 
patients will have a larger reduction of symptoms if they are treated with CBT or GCBT, as 
compared with MCBT. When considering that a difference of 0.2 - 0.4 g (which represents 
the difference in ESs between CBT and GCBT, as compared to MCBT) equates to a clinically 
meaningful change, these differences do not seem neglectable. Thus, clinicians should be 
aware that more patients will be likely to experience clinically meaningful change with the 
traditional forms of cognitive therapy. 
 When observing the temporal development of MCBT, the clinical implications are 
limited. No change has been observed with time, as treatment effects have been stable. 
Stability is thus the main message; therapists know what to expect and have little reason to 
suspect any weakening or strengthening of the clinical outcomes for the immediate future. 
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The temporal development for GCBT conveys another picture. Treatment outcomes 
have steadily increased with time, and ESs can now be expected to be roughly 0.5 - 0.6 g 
higher when compared to the trials of the 1980`s, as measured by the BDI. This statistically 
moderate difference in ES equates to a clinical meaningful change for patients, who on 
average can be expected to enjoy a 5-6 points larger reduction in depressive symptoms with 
contemporary treatment. Moreover, the data indicate that the improvement is ongoing, which 
should be of interest for therapists, treatment clinics and institutions, as well as policy makers. 
As the average pre-treatment BDI score for patients in GCBT trials for depression treatment 
was 24, a gain in symptomatic reduction of 5-6 points would mean that a substantial number 
of patients are expected to reach sub-clinical levels after treatment, thus being cured for major 
depression. 
 This is not the case for individual CBT, where ESs have fallen by roughly 50 percent 
since the 1970`s. The decline equates to a strong effect size of g = 1.1, which approximately 
equates to a 10-12 point difference in scores pre/post, as measured by the BDI and HRSD (!). 
When taken into consideration that a change of 4 points on these scales indicate that a clinical 
meaningful change has occurred, the potential clinical implications are huge. An example 
could serve to illustrate the impact: If a patient entered therapy with a diagnosis of severe 
depression, and a pre-treatment score of 31 on the BDI and HRSD, the reasonable expectation 
with contemporary treatment would be to achieve a post-treatment score of 15-22, and a 
change in diagnosis to mild depression. While such a reduction may seem quite impressive at 
face value, it must be noted that had the same patient entered therapy in the 70`s, the expected 
outcome from treatment would be a post-treatment score of 5-12, with clinical remission 
achieved from the depressive disorder. As individual CBT is the most widespread and utilized 
anti-depressive treatment format, it should be of profound clinical importance to invest efforts 
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in arresting the declining tendency in the treatment effects for CBT, and search for methods to 
regain the treatment outcomes of decades past. 
 The meta-analyses comprising the present thesis have not measured treatment outcome 
at any follow-up intervals, and thus can make no firm conclusions regarding eventual time-
trends beyond post-treatment. However, as scores on symptom checklists for depression 
typically are comparable at post treatment and follow up, it does not seem plausible to expect 
considerable deviations from the time-trends found at post-treatment. 
  
Explaining the results   
Although the exact underpinnings of the current findings were not thoroughly or 
specifically investigated in the different articles building up this thesis, there is enough 
information in the results and analyses to make several qualified reflections and hypotheses 
regarding what causes the observed effects.  
 
The placebo effect 
The placebo effect is a recognized ingredient for all forms of treatment, both somatic 
and psychological ones. Typically, it accounts for between 20 and 35 percent of treatment 
effect. An important variation in the placebo effect happens when a new form of treatment is 
available, and a spike in effect is observed in the beginning of its lifespan. This effect is 
especially pronounced the more hyped and build-up the new treatment form is, and the more 
praise and plaudits it receives. When it comes to CBT in the 1970`s, there was no shyness in 
communicating and showcasing this new and revolutionary form of therapy. Often branded as 
the “gold standard” for treatment of depression, paired with a powerful shift in paradigm 
towards a cognitive era, the expectancies and hopes for suffering patients were probably 
through the roof in the early years of CBT. In recent times, however, an increasing number of 
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studies (e.g., Baardseth et al., 2013; Wampold et al., 1997, 2002) have not found this method 
to be superior to other techniques. Coupled with the increasing availability of such 
information to the public, including the Internet, it is not inconceivable that patients’ hope and 
faith in the efficacy of CBT have decreased somewhat, in recent decades.  
Arguments such as the above, lead to the inevitable question; could the observed fall 
in ESs for CBT be completely explained by wearing of the placebo effect? The answer is 
probably “no”. First, the observed fall in treatment effects for individual CBT is not halted or 
stabilized after 10-12 years in existence, as would be expected if there was purely a “new-
therapy” related spike. Second, when scrutinizing the meta-regression line, the observed fall 
in treatment effects has seemingly gone through phases. The decline was halted around the 
turn of the century but was again evident towards the end of the period under investigation. 
Although there is a possibility for these detailed analyses to be mere statistical artefacts, the 
main result stays the same; the ESs of CBT has been, and most likely still is, in decline. 
A further question is whether a potential early spike in placebo effects could have 
influenced the temporal trends for GCBT or MBCT. However, there appears to be factors 
making this effect less significant. First, when comparing the studies on CGBT and individual 
CBT, the first article did not include any studies published before 1980, while the latter 
included five articles from the 1970`s. As both formats are cognitive behavioral, the brunt of 
an eventual spike would be connected to the earliest trials. In the same vein, MCBT would not 
be significantly affected by any initial spike connected to the brand CBT. Further, as all 
studies for MBCT was conducted in a ten-year timeframe, there is probably not a large 
enough range yet to detect any potential “new-treatment” spikes related to the invention of the 
term “mindfulness”. Whether such an effect truly exists connected with mindfulness as a 




Study quality and sample size 
When comparing trials that have been published in a timeframe approaching 40 years, 
there are specific procedural factors that may be suspected to contribute to the findings. One 
of these relates to the level of stringency connected to the individual trials, where a reasonable 
assumption is that earlier trials have a lower degree of methodological requirements, and thus 
are less robust. If this is a systematic finding, there could be a confounding factor to the 
results.  
The best indicator we have for observing stringency, or how robust trials are, is study 
quality. This is a measure which is implemented and controlled for in all the meta-analyses 
building up the current thesis. The results do not univocally confirm that study quality has 
improved with time. For paper I there was indeed observed a significant increase in 
methodological quality with time. However, for paper III, which was covering a similar 
timespan as paper I, no such relationships were found. This was also the case for paper IV, 
though here the time range is limited. An important factor to consider when interpreting these 
results, is that paper III (GCBT) included a stricter selection procedure for which trials to be 
included in the meta-analysis, as compared to paper I (CBT). The main difference related to 
the design of the studies. For paper III, all trials had to be randomized controlled trials, while 
the requirements for paper I were more including. Based on this information, the most prudent 
conclusion seems to be that study quality has not increased dramatically with time for RCTs. 
However, trials without a randomized and controlled design are less likely to be published 
with the passing of time. 
Correlation does not imply causation, so the observation of lower study quality in 
earlier trials do not necessarily explain the observed differences in effect sizes. To investigate 
any possible causation, a two-way interaction test was performed (time x study quality), to 
check for any influence on the temporal development of ES. The statistical analysis revealed 
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that no such interaction existed (p = .60), leaving the conclusion that temporal ESs did not 
systematically vary because of variations in study quality. Considering the evidence, it does 
not seem plausible that increased stringency for modern trials bear any significant part of the 
reason for the observed findings. This impression is enhanced by the findings of an increase 
in ES with time for paper III. 
 Sample size is another factor commonly thought to have a bearing on ESs and is a 
factor to consider when comparing trials from different eras. Papers I and III did not include a 
separate analysis for sample size`s influence on ESs. The assumption was that performing 
extensive checks for publication bias, implementing the Hedge`s g, and carefully investigating 
the funnel plots would adequately deal with concerns related to small samples. Indeed, the 
indicators from the tests of publication bias, and the forest plots, did point towards a potential 
confounding effect in the dataset for paper I, with smaller samples having larger effect sizes. 
As the main analyses showed significant findings, these indications were controlled for in a 
follow-up sub-analysis. Here, the 30 trials with the smallest samples were excluded, but the 
results of a falling effect with time remained significant. In paper IV (MCBT), one of the 
statistical conditions did find a significant, positive relationship between ES and sample size. 
However, when it comes to time-trends, the regression line was identical to the other 
statistical conditions in the paper.  
Based on the combined results from the three meta-analyses, it cannot be firmly 
concluded that sample size did not exert any effect at all on the outcomes. However, it is not 
considered likely that this factor explains a significant proportion of the temporal 






Attitudes and knowledge towards mental health issues and treatment 
For the past decades, there has been a positive development in western societies when 
it comes to openness for treatment for psychological disturbances, and attitudes towards 
mental illness.  The tendency is that more afflicted people seek help, and that they are 
encouraged to do so by their friends, colleagues, employers, and families. At the same time, 
people with mild psychological disturbances are not subjected to similar levels of stigma and 
discrimination. This is probably a contributing factor for the gains in treatment effects 
observed for GCBT. In a group setting consisting of typically 6-10 people, the potential 
effects of stigma, including feelings of shame, discomfort, and anxiety, would be significant. 
Thus, if most clients involved in the group setting felt less stigma, ESs would be higher. This 
effect would not be as salient when it comes to individual therapy, as there is no-one else in 
the therapy room besides the client and therapist. Such a notion could help explain why the 
declines in ESs for CBT have seemingly not been prevented by a more open-minded society.  
The article investigating MBCT also lend support to the hypothesis of a tendency 
towards a more open-minded society. For this analysis it was found that younger clients 
profited more from treatment than did the elder ones. It is considered plausible that this effect 
is mainly due to younger people (and their environment) being more open-minded towards 
treatment and psychological issues. 
 
Internet and social media 
 The last three decades have seen the introduction and growth of internet and social 
media (SoMe). With the internet being generally available for the population, an unlimited 
source of potential information is but a few keystrokes away. The invention of the internet 
could have a significant effect on the temporal development in ES for individual CBT. 
Cognitive behavioral therapy is essentially an information-based form of therapy, where the 
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main objective is to use rational and objective thoughts and evidence to counter maladaptive 
feelings. Now, with the plethora of such information readily available for the population, it is 
likely that many patients have covered this section of treatment long before entering the room 
of therapy. As such, the measured treatment-effects would likely diminish. At its birth, CBT 
was being hailed for its simplicity, and user-friendly format. The clients could understand and 
participate in their own treatment, directed by books or leaflets handed from the therapist. In 
present time this information is freely available at home. As such, it is conceivable that the 
very expansion of CBT could contribute to its lower effects - as measured by treatment trials. 
Furthermore, as CBT is considered easier to understand and less complex than many other 
forms of therapy, there is a possibility that the development of internet and SoMe would have 
a larger negative effect for CBT, compared to other forms of (less known) therapies, for 
example intensive short-term psychodynamic therapy (Davanloo, 2000). This is an avenue 
where future research is necessary. 
It is plausible that the growth of internet and social media would have a bigger impact 
on individual therapy than group therapy, as the focus on psychoeducation and theoretical 
knowledge is more pronounced for the first format. This factor could help explain some of the 
variations behind the different trends in temporal developments.  
 
Standardization and the use of a manual  
When it comes to interpreting the reasons for the observed fall in ESs associated with 
CBT, there has been widespread opinions among researchers and practitioners. Some point to 
treatment fidelity and adherence, strongly suggesting that a probable cause for the observed 
decrease in effect sizes could be found in a decrease in treatment fidelity, and/or a lack of 
adherence to a treatment manual, or cognitive therapy`s principles (Waltman, Creed & Beck, 
2016; Waltman, Sokol & Beck, 2017). The authors call for the cognitive field in 
87 
 
psychotherapy to become more aware of following the principles of CBT, and for treatment 
fidelity to be implemented as a standard measure in research trials. The underlying 
assumption is that for the earlier trials for CBT, therapists and treatments had higher levels of 
adherence and fidelity. This notion is hard to measure in any quantitative analysis though, 
because most trials are lacking the relevant information, or use differing methods for 
measuring such phenomenon. It is thus very hard to conclude that poor fidelity or adherence 
are responsible for a decline in ESs.  
What we do know, is that for GCBT a wide variety in regard to applying a manual was 
observed in paper III, with no single manual being universally embraced or utilized across 
time. Researchers frequently develop their own manuals before the start of treatment, and 
many do not follow a set manual at all. The result is both strong effects sizes, and 
improvement in effects with time. The analyses show a significant difference in ESs, favoring 
trials that did not use (or report) a set manual. Further investigations also showed that the 
statistically significant improvements with time were exclusively tied to the trials featuring no 
set manual (or not reporting one). The tendency of utilizing different manuals contrasts with 
individual CBT, where a large number of studies use the original Beck manual for CBT for 
depression (Beck et al., 1979). However, as illustrated in this thesis, this approach is not 
beneficial to the individual format either. Interaction-analyses consisting of trials for 
individual CBT showed that the steepest decline of ESs with time was tied to the trials using 
the original Beck manual. For the meta-analysis investigating MCBT, all included trials were 
based on the original treatment manual, and the timespan for investigation was limited. As 
previously noted, this study showed a virtually flat regression-line, with no changes in ESs 
with time. Thus, any conclusions concerning the use of a manual are hard to reach for this 
treatment format. However, there are indications that the widespread use of a set manual 
could have a detrimental effect for temporal improvements also for MCBT.  
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It is important to keep in mind that all the included trials adhere to the cognitive 
principles and use traditional cognitive and behavioral techniques and approaches. One of the 
keys to further improvements in ESs for all formats of CBT probably lies in moving away 
from using highly structured treatment manuals (which could lead to rigid treatment), thus 
paving the way for a more creative, adaptable, and intuitive way of conducting CBT. The 
future hallmarks of an excelling cognitive behavioral therapist could very well be the ability 
to use therapeutic creativity and adaptability, yet within a framework consisting of reasonable 
levels of competency, treatment fidelity, and adherence to general cognitive behavioral 
principles. This notion is consistent with previous research regarding the association between 
flexibility and the use of a manual (Kendall et al., 1998). More recent findings also suggest 
that therapist flexibility is associated with better treatment outcomes (Owen & Hilsenroth, 
2014). The strong importance of “manual” as a moderator for ESs becomes apparent when 
observing that the only moderator identified as exerting a significant influence on ES for 
GCBT, was whether a set manual was utilized, or not. 
 
Complex relationship between factors  
The outcomes from the different analyses, as well as the theoretical aspects discussed 
in the previous sections, point towards an identification of two robust factors associated with a 
rise in effects sizes with time: the format of group therapy, and the flexibility afforded by not 
utilizing a set treatment manual – one which could be outdated, or conducted with too much 
rigidity. The first factor is most likely a reflection of the general development of society, with 
less shame and fear of psychological issues, combined with a higher degree of openness. The 
identification of two variables facilitating positive developments of ESs with time is 
supported by the empirical and theoretical analyses, and could explain why individual 
therapy, largely consisting of two factors with a negative impact on the temporal development 
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of ES (widespread use of a set manual, in an individual format), experience a fall in ESs. 
Further, MCBT, which is largely characterized by consisting of one detrimental, and one 
facilitating factor for temporal development of ESs (widespread use of a set manual, in a 
group format), shows a standstill with time. While GCBT, consisting of two facilitating 
factors for the increase of ESs with time (flexible/varied use of manuals, in a group format) 
shows an improvement in treatment effects.  
The results thus suggest that a substantial reason for the observed decline in ES over 
time for individual CBT could be related to the use of a manual/procedure from the 1970s for 
a population from the 2000s and onwards. The variables “time” and “manual” seem to have a 
complex effect on each other, where the importance of updating the latter (and/or being 
flexible as a therapist), becomes more evident with the passage of time. The standardization 
of treatment likely results in less variability in treatment effects across time. On the other 
hand, when varying the approach, ESs increase. The findings building up this thesis strongly 
lend support to the importance of updating treatment procedures and manuals to ensure they 
are in touch with general developments in society.  
Support for the above hypothesis is also available through investigating geographical 
differences. Effect sizes from studies performed in the U.S. decreased with time for individual 
CBT, while ESs for trials from the rest of the world remained unchanged (Christea et al, 
2017). Although not specifically reported, it is reasonable to assume that trials performed in 
the U.S. utilize the original Beck manual to a higher extent, thus contributing to the observed 
fall in treatment effects, as the original manual gets more outdated for every passing year. 
This hypothesized cultural and social “goodness of fit” for psychotherapy is a concept 
that is attracting increased interest from both researchers and commentators (e.g., Burkeman, 
2015). As cultural shifts and developments have occurred at a rapid pace during the last 
decades, updates for treatment manuals should happen at a similar rate. Such a procedure 
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could also facilitate another contributor to treatment effect, the placebo effect. Hypothesized 
as a possible reason for the decline in individual CBT (Johnsen & Friborg, 2015), perhaps the 
loss of a placebo effect with time could be alleviated if manuals were updated and adjusted at 
timely intervals.  
The relationship between the factors “time” and “adherence to a treatment manual” 
could also be part of a complex explanation for a decline in treatment effects. The original 
treatment manual by Beck et al (1979) stresses that high degrees of adaptation and flexibility 
should be afforded according to the individual needs of the patient, if the adaptations do not 
deviate from the cognitive principles, and the implementation of the techniques follow the 
descriptions in the manual. It is conceivable that the therapists in earlier treatment trials were 
more aware, or attentive, to the importance of adaptation or flexibility. The first treatment 
trials for CBT as an anti-depressive treatment were led by close associates to Dr. Beck, and 
sometimes led or supervised by Beck himself. As such, the probability of following the 
general principles of the manual was probably at the highest level. With time however, it is 
possible that the more abstract concepts of flexibility and adaptation in the original manual 
have become understated and replaced with a firmer focus on how to properly implement 
treatment techniques, such as identifying and challenging automatic thoughts, measuring and 
addressing maladaptive beliefs, and provide precise psychoeducation. Such a phenomenon 
would be reflected also in measures of adherence, which are more likely to emphasize, and 
put value on, the specific ingredients of treatment. Thus, a stronger focus on adherence to the 
treatment manual may exert a detrimental effect for the crucial elements of adaptation and 
flexibility. The result could be a more rigid treatment, with less room for individual variations 
when it comes to, for example, how many sessions should be devoted to the different parts of 
CBT, or how much time should be dedicated to building the alliance, or to which extent 
emotional release should be prioritized or supported.  Researchers and clinicians of future 
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clinical trials should thus be aware of this potential pitfall, where stricter demands of 
adherence may imply moving away from highly important general principles of CBT.  
Another factor that will have a significant effect on the development of therapy in 
years to come, is the COVID-19 situation. Although the net impact is hard to predict at this 
stage of the pandemic disease, some effects are probable to occur. For example, it is likely 
that the development in the world would lead to a more favorable view in the population 
towards internet-delivered treatment programs. This shift would translate into friendlier 
attitudes, and a higher belief and assuredness towards the internet-format, thus having a 
beneficial impact on the placebo effect. On the other hand, face-to-face meetings could suffer 
from the nocebo-effects stemming from peoples fear and reluctance to enter such meetings, 
conceivably exercising a detrimental effect on treatment effects. Such a scenario, likely to 
negatively affect group-therapy the most, is a potential relevant and potent example of the 
complex interaction of factors determining treatment effects; as society changes, so does the 
requirements for therapy. What constitutes the most beneficial form of therapy today, is not 
necessarily the same as 2-3 years ago – let alone 40 years ago! Thus, the present pandemic, as 
horrible as it may be, could also serve to highlight the main message within this thesis: To 
ensure improvement in our treatment efforts, it is essential to continuously update treatment 
procedures and manuals. Otherwise, we run the risk of not being aligned with society and the 
people we are treating. 
As previously introduced, there could be a complex relationship regarding the amount 
of available information, the format of therapy, and the effect on treatment outcomes. For 
GCBT, information and knowledge of the treatment is probably not as readily accessible and 
common as for the individual format of CBT. This is partly since there are many variations 
for conducting GCBT, and because researchers and clinicians frequently develop their own 
manuals/procedures for trials and general treatment. By doing so, they are essentially 
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adhering to the theory of being in touch with societal developments. The procedures are being 
developed at the same time and place as the intervention is utilized. As such, information 
about the intervention would not become common knowledge before therapy starts, thereby 
preventing any limiting effect on either the placebo effect, or because of clients making use of 
the interventions beforehand. Further, the interventions and procedures utilized in GCBT are 
inherently much harder to practice before entering the therapy-room. After all, it requires a 
surrounding of a group consisting of similar clients. Although offering a potential explanation 
to the observed developments in ESs for CBT over time, there could be an argument made 
towards the observed associations merely revealing a shift in treatment outcome in general. If 
the patients do gain a substantial amount of helpful knowledge before entering therapy, could 
this quantify as a “real life” effect of treatment, and should it thus be considered in addition to 
the effects shown in treatment trials, or as a part of it? If so, what would the influence be on 
the “true” effect size? This is a complex question, where future research is most welcome. 
 
Variables affecting meta-analyses on time-trends   
Heterogeneity 
Heterogeneity often poses a concern with the meta-analytic approach. This especially 
holds true for meta-analyses based on pre-post within-group ESs, where an inherent risk of 
bias in the form of data dependence, also known as type-1 error, exists (Cuijpers et al., 2017). 
This risk would also apply for several of the analytic conditions building up the present thesis. 
However, data dependence is not an issue with regards to between-group calculated ESs. The 
present articles lend themselves to both procedures, calculating effect sizes through both 
between-group and within-group approaches, with the results revealing similar outcomes. 
Overall, this suggests that data dependence do not have an undue effect on the results. 
Furthermore, even if an issue of data-dependence did exist, this would mainly affect the 
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overall estimated ES of treatment, and not the targeted time-trends. The underlying 
assumption is that heterogeneity for within-groups do not systematically change with the 
passing of time. Rather, the distribution of heterogeneity is considered to randomly vary with 
the passing of time. Thus, there is little reason to assume that the time-trend results, which are 
the focus of this study, would be differentially affected by the issue of type-1 error. 
In general, high scores of heterogeneity is not an unusual phenomenon for published 
meta-analyses in the field of social and medical sciences, where about a quarter have I2 scores 
above 50% (Higgins et al., 2003). As for psychology specifically, a recent study examining 
rates of I2 in published meta-analyses in Psychological Bulletin between 1990 and 2013 (van 
Erp et al, 2017) revealed that over half of the between-study meta-analyses showed I2 > 70.  
Furthermore, it is important to emphasize that quantification of heterogeneity is only one 
component of a wider investigation of variability across studies, the most important being 
diversity in clinical and methodological aspects. This especially holds true for analyses based 
on small samples. Thus, one should be careful before assuming statistically significant 
findings as random or spurious purely on the grounds of large I2 scores. There should be other 
clear indications present before disqualifying findings.  
 
Methodical and statistical procedures  
There are several methodological and statistical choices to be made when performing a 
meta-analysis. The aim is to utilize the most precise procedure for measuring the phenomenon 
in question, in a pragmatic and prudent manner.  
Typically, current meta-analyses estimating effect sizes for psychotherapy utilize an 
intention to treat (ITT) format. With such a procedure, the estimated ESs are thought to be 
similar to what we see in real life therapy, where people not completing the course of therapy 
are also part of the equation. However, when performing meta-analyses on temporal 
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development, the ITT procedure carries a larger risk of unexplained variation with the passing 
of time. Even if the underlying assumption is that the distribution of dropouts and non-
completers is randomly distributed over the years, there is still the possibility that some trials, 
performed in particular years, have a different rate of non-completers as compared to other 
specific studies performed in other specific timeframes. Thus, for two of the meta-analyses 
building up this thesis, the active choice to calculate ESs based on completers of a trial were 
made. With such a procedure we can be certain that the measured effect sizes are based on 
patients completing therapy, regardless of the year being 1979 or 2018, leaving less room for 
unwanted variability to exist. 
As treatment for depression is an important field of psychology, much research has 
historically been performed in this area. However, a significant chunk of manuscripts never 
gets to enjoy life outside the drawer of publishing journals, leading to the issue of publication 
bias. The risk here is related to the higher probability of significant findings (i.e large effect 
sizes) to achieve publication, as compared to nil-findings (typically with low effect sizes). A 
larger meta-analysis on the issue of publication bias, found that ESs in some circumstances 
may be inflated by 40 percent (Cuijpers et al, 2010). Again, such a phenomenon can be very 
problematic when the main aim is to estimate an overall ES for treatment, as any risk for 
inflating the true effect-size is unwelcome. However, for meta-analyses on time-trends, this 
issue carries less threat. It does not really matter how many specific trials have been left in the 
drawer, as long as there is no systematical distribution of unpublished trials connected to 
certain periods of time. Fortunately, there are no indications of this being the case. 
Nevertheless, publication bias has been thoroughly examined in the present meta-analyses and 
corrected for if indicated. Such a procedure ensures that the results are dependable both from 





If relevant diagnostic criteria had been subjected to significant changes during the 
timeframe under investigation, it is reasonable to suspect such movements could have a 
bearing on the results. Major changes in diagnostic criteria implies that the current clinical 
understanding of a disorder has shifted. Such a shift would have an impact on several levels 
for research trials, with selection procedures, measures of the disorder, and the therapy itself 
being affected. However, within the time ranges for the studies under investigation in the 
current thesis, there appear to be limited moderating effects resulting from changes in 
diagnostic criteria. As the implementation of modern clinical diagnostic criteria for depression 
most likely preceded the trials included in the current meta-analyses, it is not considered a 
factor deemed plausible to have a contributing effect in explaining the observed time trends. 
After the implementation of stricter criteria in the mid to late 70`s, the DSM has only been 
subjected to rather minor diagnostic adjustments, and the clinical understanding of the 
depressive syndrome has largely remained intact. Also, the observed adjustments in the DSM 
over the last four decades do not apply for the more cognitive symptoms of guilt, suicidal 
ideation or thoughts of worthlessness, which have stayed the same from DSM-III to the 
current DSM-V. 
 
Other perspectives and recent research 
 The findings of a temporal decline in ES for individual CBT has been challenged by a 
couple of re-analyses (Christea et al, 2017; Ljótsson et al, 2017). Yet, the field of depression 
treatment has, by and large, accepted the findings as reflecting a true phenomenon – albeit 
with a plethora of hypotheses with regards to the underpinnings of the results. For example, a 
recently published paper tied some of the decline to possible differences in the control groups 
for newer versus older trials of CBT (Dobson, 2016). Another study linked the decline to a 
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lack of training, competency, treatment fidelity and/or adherence to cognitive principles by 
modern cognitive behavioral therapists (Waltman, Creed, & Beck, 2016). This stance is 
largely supported by Dobson (2016), while also noting that earlier trials to a larger extent 
were characterized as measuring efficacy, versus effectiveness for newer studies. 
 The findings from paper I regarding the achievement of higher effect sizes for 
psychologists vs trained students, have been expanded in subsequent research. A new meta-
analysis substantiated that students did indeed achieve poorer ESs from therapy than did 
trained clinicians (Goldstein et al, 2020).  
 The focus on change across time, and the development of methods for quantifying and 
measuring temporal trends of treatment effects, displayed by the meta-analyses in this thesis, 
have served as a model for further investigations in other areas of psychotherapy. For 
example, a comprehensive meta-analysis found that the rates of self-injuring thoughts and 
behaviors have not improved because of specific treatment for the last 5 decades (Fox et al, 
2020). This finding could seem counterintuitive, given the number of efforts investigated in 
understanding and preventing such behaviors. Another meta-analysis found that cognitive 
behavioral therapy for psychosis had seen an improvement with the passing of time for the 
symptom of delusions, but no significant change across time for other symptoms (Sitko et al, 
2020). Further, an extensive meta-analysis examined whether the effects of blood pressure 
lowering treatments had improved with time (Sekizawa et al, 2018). No change was observed 
for the chosen parameters. 
 The view presented in this thesis, regarding the need of systematical changes in how 
modern treatment for depression is conceived and implemented, enjoys substantial support by 
researchers in the field of depression treatment, and psychological treatment in general. A 
recent paper pointed towards a potential shift in paradigm, where the focus no longer should 
be on which therapy is the most efficient – but rather towards which kind of therapy is best 
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suited for the individual patient, in his/her situation in the here and now (Leichsenring et al, 
2018;). This point is developed further in a subsequent article by the same authors. Here, a 
suggested change in funding policies is recommended, moving on from a “more and more of 
the same” philosophy, towards more variation in which therapies receive funding 
(Leichesenring et al, 2019). The main message being that plurality is the future for 
psychotherapy, as one uniform does not fit all clients. The general idea of choosing the best 
treatment format and ingredients for the individual patient is also discussed and supported in 
other recent articles on the topic (McCormack & Chadler, 2018; Mulder et al, 2017). In a 
similar vein, another recent article investigated the potential beneficial effects of 
implementing a personalized allocation of patients to therapists (Delgadillo et al, 2020). The 
hypothesis was that by matching patients with specific characteristics to specific therapists, 
outcomes would improve. The results suggest this was indeed the case. 
A combined view encompassing both the need for plurality in psychotherapy, while 
also taking into consideration the contemporary developments of the world, leads to thoughts 
regarding therapy delivered via mobile phone applications and internet interventions. For the 
latter, a recent meta-analysis indicated that tailoring could be effective also for anti-depressive 
therapy delivered via the internet (Twomey et al, 2020). When it comes to therapy delivered 
via mobile phone applications, a recent study showed there were considerable positive effects 
on a range of mental health issues when using a CBT-based intervention (Rathbone et al, 
2017). These findings should be considered as specially promising given the state of the world 
as of the year 2021, with the coronavirus still being highly active. 
 
Limitations and strengths 
 The meta-analytic papers included in this thesis are exploratory in nature, with few 
hypotheses posed beforehand. This may reduce the certainty with which one can draw 
98 
 
conclusions. Further, reliable measures of therapist adherence or treatment fidelity were 
almost nonexistent for the included studies, making it impossible to perform highly 
informative analyses or discussions with that regard. On a more detailed level, the self-report 
inventory BDI comes in two forms, the BDI-I and the BDI-II. For some analyses, these were 
treated as interchangeable. Although the two versions are very similar, there is still a 
possibility of a confounding effect resulting from this mixture. Additionally, as the BDI and 
the HDRS do not measure improvement on a more general or global level, one cannot reliably 
generalize the effects to areas beyond symptom relief. Further, none of the included meta-
analyses cover follow-up scores, which means that such results and information, with 
potential high clinical value, are not available. For papers I and III, this choice was made 
based on large variations in which individual trials included follow-up data, with especially 
several older trials lacking. Finally, the meta-analyses building up the current thesis do not 
check or control for researcher allegiances. However, the main problems associated with 
allegiance are not as pronounced in a temporal design, as in a comparative design. When 
comparing different forms of treatment, a potential inflation of ESs may obviously exert a 
large effect on the conclusion. For the current temporal analyses though, the underlying 
assumption is that any research allegiance will vary in a random manner with time, and thus 
most likely will not exert any systematical or confounding effects on the results. As far as the 
author is aware, there are no literature or research indicating that researcher allegiance was 
more pronounced in seminal or modern trials.  
 The methodical and statistical allegiance and rigidity are considered major strengths 
for this thesis. The included articles perform meta-analyses with a highly similar template, 
allowing comparisons across studies. Further, the current concept of reliably defining and 
measuring time-trends represents an innovation for the field of psychotherapy. This thesis also 
encompasses and investigates the major branches of CBT (individual, group, and 
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mindfulness-based CBT), thus representing a broad evaluation of the cognitive-based 
treatment of depression. A final aspect worth mentioning as a strength relates to the affiliation 
of the main author. The doctoral candidate does not have any links, ties, interests, or 
connections to any specific branches of therapy. The present thesis should thus be considered 
to meet the highest standards of objectivity. 
 
Implications and future research 
 The background and main purpose for the present thesis and its articles was to 
investigate a previously largely unknown factor; the temporal development of CBT-related 
treatment for depression. The focus and findings discussed in this thesis are important and 
pave the way for future research in psychology in general. Efforts to investigate temporal 
developments are spreading throughout the field and will gain us further knowledge and 
insight for years to come, driving the profession forward. As a contributing factor to better 
understand the relationship between therapeutic flexibility/rigidity and treatment outcome, 
future trials in the field of depression treatment would benefit from implementing a common 
scale for measuring adherence to the treatment manual. In addition, such a scale should 
proviode checks for both adherence to the general principles of the treatment manual, as well 
as to the implementation of specific techniques. 
 From a clinical point of view, future research investigating potential temporal 
treatment effects at follow up intervals is important. The current meta-analyses do not give 
any precise indications as to whether the presented results and trends are similar 1 or 2 years 
after completion of treatment. 
 As for the specific findings related to CBT as an anti-depressive treatment, this thesis 
has provided strong evidence towards the importance of continuously updating, or adapting, 
treatment procedures and treatment manuals. Further research should thus emphasize efforts 
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in this direction. Here lies an important challenge for CBT specifically, and for clinical 
therapy in general. Further, the development of methods for identifying which patients (and 
individual characteristics) are suited for the different forms of therapies, are hugely welcome. 
The results from the present articles provide a potential start on such a journey, by 
indicating certain characteristics that could help differentiate which clients would profit most 
from CBT, and the formats of individual or group therapy. For example, clients who are 
highly enlightened and updated on psychology and cognitive principles in advance of starting 
therapy, are probably more likely to not get the full beneficial effects of a standard cognitive 
behavioral therapy as it is conducted today. Many of the steps in the manual will be well-
known and practiced by the clients beforehand, thus diminishing initial response. Such 
patients could be allocated to other forms of (less known) therapies. Further, higher levels of 
open-mindedness most likely indicate a more beneficial outcome from the less standardized, 
more flexible, and more social format of group cognitive therapy, while the more 
conscientious and closed personality type probably would get better gains from the more 
structured and organized individual CBT.  
The general importance of being adaptive in society is probably at its most 
pronounced in the year of 2021. The spread of COVID-19 has had a huge impact on people’s 
lives, and as such also for the way therapy is delivered. Many regions and countries have seen 
an increase in digitally delivered therapy. Therefore, research efforts for the immediate future 
should be directed towards finding the best way of adapting CBT to the highly relevant 
formats of mobile applications and the internet. Such a focus could also have the additional 
benefit of making help via anti-depressive therapy available for even more struggling people. 
The modern society consists of a significant amount of (more or less) data-bound individuals. 
This group’s opportunity to get into a treatment program would be immensely enhanced by 




Cognitive behavioral therapy is effective as an anti-depressive treatment. This applies 
both for the more recent adaptation in the form of mindfulness-based CBT, and even more so 
for the traditional individual and group CBT. However, the analyses showed vast differences 
in time-related effects for the three formats of CBT: The treatment effects for individual 
therapy are decreasing with the passage of time, GCBT has an increase in treatment effect, 
while MCBT show no tendencies in either direction. The main explanation for the different 
outcomes is probably due to two factors: the application of a set (and perhaps outdated) 
treatment manual, and the format of therapy (group vs individual). Individual therapy and the 
utilization of a set manual seem to be factors associated with a fall in treatment effect with 
time, while group therapy, and a more flexible approach to the treatment program are factors 
facilitating an increase in ES. Although the factors “group format” and “no set manual” may 
facilitate an improvement in ES with time, one cannot draw the conclusion that group therapy 
is (or will become) the most efficient modality of treatment for depression. Nor is it possible 
to state that a treatment without any form of manual would be better. 
However, the results strongly indicate that a new approach is needed for traditional 
CBT to maintain its standing and treatment effects: Moving towards a more adaptive and 
flexible implementation and mindset would ensure even more clients recover from depression 
through the aid of CBT. It is thus considered to be of pivotal importance to frequently and 
continuously update and adapt treatment manuals to ensure they meet the dynamic and ever-
changing requirements of modern society. What was considered the most efficient treatment 
10-15 years ago, is most likely lagging today. Further, the beneficial effects provided by 
adopting a more adaptive and flexible approach towards therapy also extends to therapy forms 
and formats. Having a variety of different forms and formats for anti-depressive treatment 
would be beneficial for the patients and provide psychological treatment clinics with the tools 
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to help even more clients. Plurality, flexibility, and adaptation are thus keywords in our efforts 
to help more clients recover from depressive disorders. Perhaps we soon could witness the 
development of a more efficient system, with effective screening tools for accurately 
distributing the individual patients to the therapy form and the therapist which suits their 
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Recent studies suggest that the effects of cognitive therapies for depression show systematic changes over time. A meta-analysis was conducted to explore the
temporal development of the effect of mindfulness-based cognitive therapy (MBCT) for current depression in studies that used the Beck Depression Inventory
(BDI) or the Hamilton Depression Rating Scale (HDRS) as outcome measures. A systematic search of research databases yielded 20 studies that were included
in the analyses. The results showed that MBCT is effective in reducing depressive symptoms. The effect sizes of studies using the BDI or the HDRS as an
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INTRODUCTION
With an estimated global prevalence of 4.4% (WHO, 2017),
depression is one of the most common and frequently occurring
mental disorders, with a high rate of relapse and recurrence
(Steinert, Hofmann, Kruse, & Leichsenring, 2014). As such,
depression represents a significant burden on the individual and
society (Whiteford, Degenhardt, Rehm, Baxter, Ferrari, Erskine,
& Vos, 2013).
A variety of psychological therapies, including cognitive
therapy (CT), behavioral activation therapy, interpersonal therapy
and short-term psychodynamic therapy, have been shown to be
effective in the treatment of depression (Cuijpers, 2017).
Recently, mindfulness-based cognitive therapy (MBCT; Crane,
2009; Segal, Williams, & Teasdale, 2002; Segal, Williams,
Teasdale, & Kabat-Zinn, 2013) was developed as a modification
of CT to specifically prevent the relapse and recurrence of
depressive episodes in individuals who had recovered from
depression (Lau, 2016). MBCT is a manual-based treatment that
combines exercises in mindfulness training with cognitive
techniques. The integration of mindfulness practice with cognitive
interventions distinguishes MBCT from other mindfulness-based
interventions (MBIs), such as mindfulness-based stress reduction
(Kabat-Zinn, 1990). The overall goal of MBCT is to increase
metacognitive awareness (Lau, Segal, & Williams, 2004) and,
thereby, reduce cognitive and emotional reactivity (Gu, Strauss,
Bond, & Cavanagh, 2015).
Studies have shown that MBCT is effective in reducing the
relapse and recurrence of depression (Kuyken, Warren, Taylor,
Whalley, Crane, Bondolfi, & Schweizer, 2016; Piet & Hougaard,
2011). MBCT seems to be equally effective in reducing risk of
relapse as CBT (Farb, Anderson, Ravindran, Hawley, Irving,
Mancuso, & Segal, 2018) and more effective than antidepressant
medications in this regard (Kuyken et al., 2016). Although, in an
early paper, the developers of MBCT cautioned against using
MBCT to treat treating patients with acute depression (Teasdale,
Segal, Williams, Ridgeway, Soulsby, & Lau, 2000), MBCT has
subsequently been extended to this group. The treatment of
current unipolar depression with MBCT follows the original
manual by Segal et al. (2013) and is delivered in a group format
with up to 12 participants and one or two instructors. After an
individual pretreatment interview in which the participant’s
history of depression is discussed and information about MBCT is
provided, the treatment consists of eight weekly two-hour sessions
(Baer & Walsh, 2016).
Several meta-analyses have shown that mindfulness-based
interventions (MBIs) in general (e.g., Goldberg, Tucker, Greene,
Davidson, Wampold, Kearney, & Simpson, 2018; Goyal, Singh,
Sibinga, &, Singh, & Sibinga&&, 2014; Hedman-Lagerl€of,
Hedman-Lagerl€of, & €Ost, 2018; Hofmann, Sawyer, Witt, & Oh,
2010; Khoury, Lecomte, Fortin, Masse, Therien, Bouchard, &
Hofmann, 2013; McCarney, Schulz, & Grey, 2012; Strauss,
Cavanagh, Oliver, & Pettman, 2014; Wang, Li, Zheng, Xu, Ng,
Ungvari, & Xiang, 2018), and MBCT in particular (Galante,
Iribarren, & Pearce, 2013; Hofmann et al., 2010; Klainin-Yobas,
Cho, & Creedy, 2012; Lenz, Hall, & Bailey Smith, 2016), are
effective in reducing depressive symptoms. For example, a recent
meta-analysis of randomized controlled trials (RCTs) observed
effect sizes (ESs) of d = 0.59 for MBIs vs. no treatment and
d = 0.38 for MBIs vs. active control conditions (Goldberg et al.,
2018). For MBCT specifically, similar or higher ESs for the
reduction of depressive symptom severity have been reported. For
example, Hofmann et al. (2010) observed an average ES of 0.85
(Hedges’s g) in nine pre-post studies. Lenz et al. (2016) reported
mean ES of g = 0.76 and 0.54 for MBCT vs. waitlist or no
treatment and for MBCT vs. alternative treatments, respectively,
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in RCTs. Recently. Goldberg, Tucker, Greene, Davidson,
Kearney, and Simpson (2019) found that MBCT was superior to
non-specific control conditions (d = 0.71) at posttest but not more
effective than other active treatments (d = 0.00).
In previous meta-analyses of MBCT for acute depression, the
temporal development of ESs in treatment studies has received little
attention. This may not be surprising, as MBCT is a relatively new
development. However, the investigation of the relationship
between time of study and ES is important, as it informs about time
trends and developments that can be positive or negative and call
for action. For example, a decline in ESs for individual CBT for
depression has been observed in published studies over time using a
version of the Beck Depression Inventory (BDI; Beck, Steer, &
Brown, 1996; Beck, Ward, Mendelson, Mock, & Erbaugh, 1961)
and/or the Hamilton Depression Rating Scale (HDRS; Hamilton,
1960) as outcome measures (Cristea, Stefan, Karyotaki, David,
Hollon, & Cuijpers, 2017; Johnsen & Friborg, 2015). Several
possible explanations for these findings have been discussed,
including more heterogeneous and complex samples in more recent
trials, therapist training, and lack of adherence to the treatment
manual (Dobson, 2016; Johnsen & Friborg, 2015; Waltman, Creed,
& Beck, 2016). In contrast, an increase in ESs for group CBT for
depression was observed when the BDI was used as outcome
measure but was not observed when the HDRS was used (Johnsen
& Thimm, 2018). As MBCT is an anti-depressive treatment that
shares key concepts and features with traditional CBT and usually
is delivered in a group format, the investigation of the time-trends
connected to this treatment form can give new and relevant insights.
For example, combined with the previous research on the temporal
development of ESs in studies of individual CBT and group CBT,
analyses such as the present one can provide indications as to
whether any time-trends can be connected to the treatment format
(group vs. individual therapy), or, alternatively, can be related to the
focus of the interventions rather than the treatment format.
Thus, the aim of the present exploratory study is to examine
the effect of MBCT on the treatment of current depression and
the development of ESs over time. Since the BDI and the HDRS
are the most widely used instruments for evaluating the
effectiveness of cognitive therapies for depression (Johnsen &
Friborg, 2015), the analysis will focus on studies that used the
BDI and/or the HDRS as outcome measures to allow for time
trends of depression treatment to be compared with previous
studies. In the analysis, studies comparing MBCT to control
condition with and without active treatments and studies
examining pre-post differences were included. Recently, it has
been suggested that ESs based on within-group scores should be
avoided in meta-analysis if possible (Cuijpers, Weitz, Cristea, &
Twisk, 2017). While there is no doubt that between-group RCTs
is the gold standard when it comes to conduct meta-analysis, there
are also several salient reasons why the inclusion of within-group
based ESs could be helpful - albeit used with caution when it
comes to interpretation of the results. First, the scope of papers
could be greatly expanded, which would increase the statistical
power. Second, we believe that meta-analyses on time-trends are
not as vulnerable to some of the pitfalls as meta-analyses
measuring standard treatment effects. For example, one common
objection to within-group pre-post standardized mean differences
is that they are influenced by natural processes and characteristics
of patients and settings, which cannot be discerned from the
effects of the intervention. However, when it comes to research of
temporal developments in treatment efficacy related to any
particular treatment form, variations in the characteristics of
patients and settings (as well as general environment and society)
could very well be highly relevant moderators to consider when it
comes to interpreting the reasons behind any temporal
development of treatment effects. Identification of any
characteristics or processes that change systematically with the
passing of time, influencing treatment effects, are of major
importance. Finally, the most accurate indicator of reliability for
any pre-post ES-calculation is heterogeneity. If this index is at a
satisfactorily level, within-group ES’s could be an informative
calculation of ESs. With these considerations in mind, we have
for the present study chosen to perform a primary analysis
utilizing between-group RCT-based ESs, and a secondary analysis
utilizing within-group ESs. We expect that the outcomes of the
two calculations regarding the temporal development of ESs
would be similar and thus validate each other’s results.
METHODS
To identify relevant studies, a systematic search was conducted in research
databases MEDLINE, PsychINFO and EMBASE on January 20, 2018.
The broad search query “mindfulness AND depress*” was used to
minimize the risk of missing relevant studies. In addition, previous
systematic reviews and published meta-analyses of MBIs for mental
disorders were manually searched. After removal of duplicates, in the first
stage of the study selection, the titles, abstracts, types of references, and
language of publication were screened by the first author. In the second
round, both authors assessed the full text of studies for eligibility. The
following inclusion criteria were applied: 1) MBCT was given in a group
format aimed at reducing depression; 2) participants were adults
(≥18 years of age) diagnosed with depression or showing elevated scores
on the BDI (> 13) or the HDRS (> 8), as a group; 3) a version of the BDI
or the HDRS was used as an outcome measure; and 4) publication was in
English and was in a peer-reviewed journal. Studies were excluded when
1) MBIs other than MBCT were examined, 2) no treatment effects for
MBCT were investigated or reported, 3) depression was not the principal
problem of the participants; 4) partial or complete sample overlap with a
study already included in the meta-analysis was observed, 5) information
necessary to calculate ES (i.e., means and standard deviations) was
lacking, or 6) only dichotomous outcomes (e.g., relapse) were reported.
For each study included in the meta-analysis, the following information
was extracted: 1) year of publication; 2) sample size of the MBCT group
and the control group; 3) mean age and percentage of females in the
MBCT group; 4) number of sessions; 5) modification of the treatment
manual by Segal et al. (2002) or Segal et al. (2013); 6) use of the BDI or
BDI-II as outcome measure; 7) no treatment vs. active treatment
comparison groups; 8) randomization of participants; and 9) reporting
results of intent-to-treat (ITT) analyses.
For the meta-analytic calculations, means and standard deviations of the
BDI and/or the HDRS at pre-treatment and post-treatment were extracted
for the treatment group and, if present, for the control group(s).
To assess the methodological quality of the studies included in the meta-
analysis, the Jadad scale (Jadad, Moore, Carroll, Jenkinson, Reynolds,
Gavaghan, & McQuay, 1996) was used. Both authors assessed the studies
independently. Rater agreement was calculated using double entry
intraclass correlation (McCrae, 2008). The coefficient for study quality was
.91. Discrepant ratings were clarified and resolved through discussion.
To obtain the ES for each study, the standardized mean difference
(SMD) between the intervention group and control group, and/or the
pretest and the posttest was calculated correcting for bias (Hedges’ g).
Following the recommendations by Rosenthal (1993), a conservative pre-
© 2020 The Authors. Scandinavian Journal of Psychology published by Scandinavian Psychological Associations and John Wiley & Sons Ltd
2 J. C. Thimm and T. J. Johnsen Scand J Psychol (2020)
post correlation of .7 was set. The mean ES across studies was calculated
using a random effects model. The analyses were conducted separately for
controlled studies (between-group) with and without active treatment
comparisons and pre-post differences (within-group) and for the BDI/BDI-
II and HDRS as outcome measures. When data for ITT samples were
available, these were preferred over data from completer samples.
To examine publication year as moderator for the pooled ES, meta-
regression analysis was used.
Heterogeneity among studies was assessed using Q tests and the I2
statistic (Higgins, Thompson, Deeks, & Altman, 2003), which is a
measure of the proportion of the total variance across studies that is due to
heterogeneity. Higgins et al. (2003) suggest that I2 values of 25% indicate
low heterogeneity, 50% indicate moderate heterogeneity, and 75% indicate
high heterogeneity between studies.
To assess publication bias, funnel plots were obtained, and Duval and
Tweedie’s (2000) trim and fill method was used to estimate the number of
missing studies and the ESs after imputation of the missing studies.
All analyses were conducted in Comprehensive Meta-Analysis version
3 (CMA; Borenstein, Hedges, Higgins, & Rothstein, 2017).
RESULTS
Study selection
After duplicates were removed, the search resulted in 4,010
unique studies. In the screening process, 3869 studies were
excluded. One hundred forty-one full-text articles were retrieved,
121 of which were excluded based on the eligibility criteria.
Thus, 20 eligible studies were retained for the meta-analysis (see
Figure 1 for the flowchart of the selection process).
Study characteristics
The study characteristics are displayed in Table 1. The included
studies were published between 2007 (Kenny & Williams, 2007;
Kingston, Dooley, Bates, Lawlor, & Malone, 2007 and 2017
(Greenberg, Shapero, Mischoulon, & Lazar, 2017). The average
number of participants in the MBCT condition was 41.2 (SD = 46.2,
range 6 to 212). The total number of participants was 824. In ten
studies, the original MBCT manual was modified to adapt the
treatment to the target group. Eighteen studies were RCTs (14) or
included a control condition without randomization (4). Seven of
these 18 studies included an active control condition (antidepressant
medication in three studies, and psychological treatment in four
studies). Two studies had two control groups (Hosseinian,
Shahtaheri, Ebrahimi, Mahdavi, & Sepahvandi, 2016; Michalak,
Schultze, Heidenreich, & Schramm, 2015). Two studies used a pre-
post design. Treatment outcome was measured with a version of the
BDI in 15 between-group studies and two within-group studies and
with the HDRS in nine between-group studies. As to study quality,
the average Jadad score was 1.90 (SD = 1.17, range 0–3).
Effects of MBCT on current depression and analysis of time
trends
The average weighted ES for between-group studies using a no-
treatment control group and the BDI as an outcome measure
(n = 11) was g = 0.92 (95% CI [0.70, 1.14]; Q(10) = 17.45,
p = 0.065, I2 = 42.7). The trim and fill method suggested that
two studies were missing, and the imputed point estimate was
g = 0.86 (95% CI [0.63, 1.08]). When an active treatment
comparison group was included (n = 5), the ES for the BDI was
g = 0.45 (95% CI [0.09, 0.80];Q(4) = 11.16, p = 0.025,
I2 = 64.2). The trim and fill method suggested that no studies
were missing. For the between-group studies using the HDRS and
a no-treatment control group (n = 7), the ES was g = 0.80 (95%
CI [0.61, 0.99]; Q(6) = 7.15, p = 0.308, I2 = 16.04). The trim
and fill method suggested that two studies were missing, and the
imputed point estimate was g = 0.72 (95% CI [0.51, 0.92]). For
studies using an active treatment control group and the HDRS
(n = 4), the mean weighted ES was g = 0.37 (95% CI [0.21,
0.54]; Q(3) = 2.62, p = 0.454, I2 = 0). The trim and fill method
suggested that one study was missing, and the imputed point
estimate was g = 0.34 (95% CI [0.12, 0.56]).
With respect to pre-post differences on the BDI, studies using a
within-group design were pooled with between-group studies
(n = 17), resulting in an ES of g = 0.90 (95% CI [0.70, 1.09]; Q
(16) = 120.36, p < .001, I2 = 86.7). The trim and fill method
suggested that no studies were missing. The ES of the
Abolghasemi, Gholami, Narimani, and Gamji (2015) study was
considerably larger than the ESs of the other studies (g = 5.18,
95% CI [3.70, 6.70]). When the Abolghasemi et al. (2015) study
was removed from the analysis, the average weighted ES was
g = 0.82 (95% CI [0.66, 0.99], Q(15) = 84.27, p < .001,
I2 = 82.2). There were no within-group studies that used the
HDRS as an outcome measure. ESs for the individual studies are
presented in Figures 2 through 6.
Visual inspections of the funnel plots revealed largely
symmetrical distributions. The funnel plots of the observed and
imputed studies are provided in the supplemental material Figures
S1 to S5.
Analysis of time trends showed no significant relationships
between year of publication and ES for between-group studies
with the BDI as an outcome measure and with no-treatment
comparisons (b = 0.03, 95% CI [0.11, 0.05], p = 0.440),
active treatment comparisons (b = 0.02, 95% CI [0.28, 0.24],
p = 0.863), and in pre-post designs (b = 0.01, 95% CI [0.07,
0.05], p = 0.657, and b = 0.03, 95% CI [0.08, 0.01],
p = 0.155 when the Abolghasemi et al. (2015) study was
excluded). For studies using the HDRS, the associations between
year of publication and ES were not significant for between-group
comparisons with no treatment (b = 0.04, 95% CI [0.13,
0.05], p = 0.348) and active treatment comparisons (b = 0.10,
95% CI [0.95, 0.74], p = 0.810).
Analysis of other moderators
In addition to year of publication, sample size, average age,
gender distribution, and baseline level of depression in the MBCT
group, as well as study quality (Jadad score), were examined as
moderators. None of these variables moderated the ESs of
between-group studies with no-treatment controls using the BDI
(sample size: b = 0.00, 95% CI [0.01, 0.00], p = 0.389; age:
b = 0.01, 95% CI [0.07, 0.05], p = 0.758; gender:
b = 0.01, 95% CI [0.03, 0.02], p = 0.677; baseline
depression: b = 0.02, 95% CI [0.02, 0.06], p = 0.262; study
quality: b = 0.07, 95% CI [0.28, 0.15], p = 0.546) or the
HDRS (sample size: b = 0.00, 95% CI [0.01, 0.01], p = 0.624;
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age (b = 0.04, 95% CI [0.12, 0.04], p = 0.313; gender:
b = 0.02, 95% CI [0.00, 0.03], p = 0.087; baseline depression:
b = 0.02, 95% CI [0.05, 0.01], p = 0.271; study quality:
b = 0.07, 95% CI [0.48, 0.33], p = 0.727). No moderation of
these variables was also found for studies with active treatment
comparisons using the BDI (sample size: b = 0.00, 95% CI
[0.01, 0.01], p = 0.835; age: b = 0.01, 95% CI [0.04, 0.03],
p = 0.752; gender: b = 0.02, 95% CI [0.01, 0.05], p = 0.252;
baseline depression: b = 0.00, 95% CI [0.06, 0.06], p = 0.908;
study quality: b = 0.30, 95% CI [0.78, 0.17], p = .208) and
the HDRS (sample size: b = 0.00, 95% CI [0.00, 0.00],
p = 0.183; age: not enough studies; gender: b = 0.01, 95% CI
[0.03, 0.01], p = 0.462; baseline depression: b = 0.01, 95% CI
[0.01, 0.04], p = 0.177; study quality: b = 0.03, 95% CI
[0.31, 0.25], p = 0.854).
For within-group comparisons using the BDI, sample size
(b = 0.00, 95% CI [0.01, 0.00], p = 0.013), age (b = 0.08,
95% CI [0.12, 0.03], p < 0.001), and baseline depression
(b = 0.04, 95% CI [0.01, 0.06], p = 0.002) were significant
moderators, but sex (b = 0.01, 95% CI [0.03, 0.01],
p = 0.353) and study quality (b = 0.14, 95% CI [0.29, 0.01],
p = 0.078) were not. When the Abolghasemi et al. (2015) study
was excluded from the analyses, sample size (b = 0.00, 95% CI
[0.01, 0.00], p = 0.002) and baseline depression (b = 0.03, 95%
CI [0.00, 0.05], p = 0.020) were significant moderators but not
age (b = 0.03, 95% CI [0.07, 0.01], p = 0.110), sex
(b = 0.00, 95% CI [0.02, 0.02], p = 0.976), and study quality
(b = 0.10, 95% CI [0.24, 0.05], p = 0.202). Thus, smaller
sample size and higher baseline depression was associated with
higher ESs across statistical conditions.
DISCUSSION
The present meta-analysis explored the development of ESs for
MBCT over time in the treatment of current depression in studies
that used the BDI or the HDRS as outcome measures. Previous
findings indicated significant changes in the ESs of individual and
group CBT for depression over time (Cristea et al., 2017; Johnsen
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- outcome measure not 
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Fig. 1. Flowchart of the search and selection procedure.
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& Friborg, 2015; Johnsen & Thimm, 2018). The main goal of the
present study was, therefore, to examine if reported time trends of
ESs for MBCT for depression could be observed in the different
studies.
The results showed that the ESs of studies using between- and
within-group designs and the BDI or the HDRS as an outcome
measure were not moderated by the time of publication. In
previous studies of time trends of ESs, diverging results for the
BDI and HDRS have been observed (e.g., Johnsen & Thimm,























Chronic depression yes 16 TAU (15) yes 8 BDI-II 3
Chiesa, Castagner, Andrisano,
Serretti, Mandelli, Porcelli, and
Giommi (2015)1











yes 19 Waitlist (23) yes 8 BDI-II 3
De Raedt, Baert, Demeyer,
Goeleven, Raes, Visser, and
Speckens (2012)
Former depression no 44 No intervention
(26)
no 8 BDI-II 0
Eisendrath et al. (2008)1 Treatment-resistant
depression
yes 55 none n/a 8 BDI-II 0
Eisendraht et al. (2015) Depression yes 19 Antidepressant
management (17)
no 8 HDRS 1





no 63 Waitlist (66) yes 8 HDRS 3
Godfrin and van Heeringen
(2010)1
Recurrent depression no 52 Waitlist (54) yes 8 BDI-II
HDRS
3















Dysthymia no 22 Medication (22) yes 8 BDI-II 2




yes 8 HDRS 1
Kenny and Williams (2007) Treatment-resistant
depression
no 46 none n/a 8 BDI 0
Kingston et al. (2007) Recurrent depression no 6 Waitlist (11) no 8 BDI-II 1
Kuyken, Hayes, Barrett, Byng,
Dalgleish, Kessler, and Byford
(2015)1





Manicavasgar, Parker, and Perich
(2011)
Depression yes 19 CBT (26) yes 8 BDI-II 2
Mann, Kuyken, O’Mahen,
Ukoumunne, Evans, and Ford
(2016)1
Previous depression yes 19 TAU (19) yes 8 BDI-II 3









Speckens, and Rinck (2014)
Remitted depressed
patients
no 28 Waitlist, patients
treated for
depression (26)
no 8 BDI-II 1
1Results from intent-to-treat analyses reported. n/a = not applicable.
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2018) and have been related to the different ways of
administration of the two instruments: the BDI is a self-report
inventory, while the HDRS is rated by a clinician. In addition, the
BDI assesses cognitive symptoms of depression to a higher
degree than does the HDRS, which focuses more on somatic
symptoms (cf. Wampold & Imel, 2015). Thus, while a decline in
ESs for individual CBT for depression and an increase in ESs for
group CBT have been observed (Cristea et al., 2017; Johnsen &
Friborg, 2015; Johnsen & Thimm, 2018), no effects of time for
the ESs of MBCT were found. Neither were there any indications
of potential trends towards a decline or increase in ES, as the
regression line was nearly neutral (flat) for all statistical
conditions. A probable reason for this finding is that studies of
MBCT for depression have used heterogeneous samples from the
beginning, i.e., included participants with various conditions in
addition to depression and had no strict exclusion criteria (cf.
Dobson, 2016). On the other hand, an improvement in ESs over
time was not observed either. It can only be speculated whether
the reported ESs of MBCT for current depression already
represent the upper limit of its effectiveness or whether factors
such as insufficient therapist training and supervision (cf.
Waltman et al., 2016) inhibit an increase of the effects.
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Barnhofer et al. (2009) 1,033 0,374 0,140 0,301 1,766 2,765 0,006
Chiesa et al. (2015) 0,662 0,308 0,095 0,057 1,266 2,145 0,032
Crane et al. (2008) 0,859 0,318 0,101 0,236 1,483 2,700 0,007
De Raedt et al. (2012) 0,786 0,253 0,064 0,289 1,283 3,101 0,002
Godfrin & van Heeringen (2010) 1,367 0,215 0,046 0,946 1,787 6,371 0,000
Greenberg et al. (2017) 1,787 0,462 0,214 0,881 2,693 3,865 0,000
Kingston et al. (2007) 1,464 0,543 0,295 0,400 2,529 2,695 0,007
Mann et al. (2016) 0,317 0,320 0,102 -0,310 0,944 0,992 0,321
Michalak et al. (2015) 0,883 0,246 0,061 0,400 1,365 3,586 0,000
Van Alderen et al. (2012) 0,647 0,143 0,020 0,367 0,926 4,528 0,000
Verhoeven et al. (2014) 1,125 0,289 0,084 0,558 1,692 3,887 0,000
0,923 0,113 0,013 0,702 1,144 8,183 0,000
-1,00 -0,50 0,00 0,50 1,00
Favors A Favors B
Fig. 2. Forest plot for between-group studies using the BDI and no-treatment control groups.
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Abolghasemi et al. (2015) 0,512 0,361 0,131 -0,197 1,220 1,416 0,157
Hamidian et al. (2013) 1,344 0,329 0,108 0,699 1,988 4,085 0,000
Kuyken et al. (2015) 0,397 0,098 0,010 0,205 0,589 4,055 0,000
Manicavasgar et al. (2011) 0,123 0,297 0,088 -0,459 0,705 0,414 0,679
Michalak et al. (2015) 0,071 0,235 0,055 -0,389 0,532 0,304 0,761
0,446 0,180 0,032 0,093 0,799 2,474 0,013
-1,00 -0,50 0,00 0,50 1,00
Favors A Favors B
Fig. 3. Forest plot for between-group studies using the BDI and active treatment control groups.
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Chiesa et al. (2015) 1,004 0,319 0,102 0,378 1,629 3,146 0,002
Geschwind et al. (2011) 0,840 0,183 0,033 0,481 1,198 4,595 0,000
Godfrin & van Heeringen (2010) 1,116 0,208 0,043 0,709 1,522 5,375 0,000
Greenberg et al. (2017) 1,037 0,429 0,184 0,197 1,878 2,419 0,016
Hosseinian et al. (2016) 0,854 0,413 0,171 0,044 1,663 2,067 0,039
Michalak et al. (2015) 0,362 0,237 0,056 -0,102 0,826 1,528 0,126
van Alderen et al. (2012) 0,685 0,143 0,021 0,405 0,966 4,785 0,000
0,798 0,096 0,009 0,610 0,987 8,320 0,000
-1,00 -0,50 0,00 0,50 1,00
Favors A Favors B
Fig. 4. Forest plot for between-group studies using the HDRS and no-treatment control groups.
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As to the overall effect of MBCT for acute depression, the
results of the present study are consistent with previous meta-
analytic studies (e.g., Goldberg et al., in press; Lenz et al., 2016),
suggesting that MBCT is effective in reducing symptoms of
depression. Applying Cohen’s (1992) criteria, the average ESs for
between-group studies comparing MBCT to no-treatment control
conditions and pre-post studies were large for both outcome
measures. Studies with active control conditions showed moderate
average ESs in favor of MBCT. The trim and fill method
indicated that publication bias was present for three of the five
meta-analytic conditions. However, the estimated number of
missing studies did not exceed two, suggesting that overall
publication bias is low. Consistent with previous findings (e.g.,
K€uhberger, Fritz, & Scherndl, 2014), there was a negative
association between sample size and ES in within-group studies,
i.e., studies with smaller samples tended to show higher ES than
studies with larger samples. Similarly, higher baseline levels of
depression were related to higher ESs. Based on the robust
finding of the effectiveness of MBCT for current depression, it
has been proposed that MBCT should be offered as a first-line
treatment for depression on equal terms with other evidence-based
treatments (Strauss et al., 2014). However, more research is
needed to support this claim. It should be noted that the average
ES observed for MBCT when compared to no treatment
comparisons is lower than those for other psychological
treatments. For example, for individual and group CBT, average
ESs of g = 1.37 and g = 1.14, respectively, have been reported
for between-group studies using the BDI (Johnsen & Friborg,
2015;Johnsen & Thimm, 2018). The corresponding ES for MBCT
in the current study was g = 0.92. Additionally, for pre-post
comparisons, the average ES for MBCT observed in the present
study (g = 0.90, g = 0.82 when the Abolghasemi et al. (2015)
study was excluded) is smaller than those for individual and
group CBT in clinical trials (g = 1.65 and g = 1.33, respectively;
Johnsen & Friborg, 2015; Johnsen & Thimm, 2018) and in
routine clinical practice (d = 1.06; Hans & Hiller, 2013).
When interpreting the results of the present investigation,
several limitations have to be considered. Compared to previous
examinations of temporal development of the effects of CBT for
depression, the period in which the studies investigating the
effects of MBCT for depression were conducted was relatively
short. Further, the number of available studies was small.
Chronicity of depression and an assessment of adherence to the
MBCT manual was not reported in most publications and could,
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Eisendraht et al. (2015) 0,537 0,306 0,093 -0,062 1,136 1,758 0,079
Hosseinian et al. (2016) 0,314 0,397 0,157 -0,464 1,092 0,792 0,429
Kuyken et al. (2015) 0,304 0,098 0,010 0,113 0,495 3,120 0,002
Michalak et al. (2015) 0,699 0,242 0,059 0,224 1,173 2,887 0,004
0,371 0,085 0,007 0,205 0,537 4,378 0,000
-1,00 -0,50 0,00 0,50 1,00
Favors A Favors B
Fig. 5. Forest plot for between-group studies using the HDRS and active treatment control groups.
Study name Statistics for each study Hedges's g and 95% CI
Hedges's Standard Lower Upper 
g error Variance limit limit Z-Value p-Value
Abolghasemi et al. (2015) 5.182 0.757 0.573 3.699 6.665 6.847 0.000
Barnhofer et al. (2009) 1.070 0.235 0.055 0.609 1.531 4.553 0.000
Chiesa et al. (2015) 0.658 0.173 0.030 0.319 0.997 3.802 0.000
Crane et al. (2008) 0.578 0.185 0.034 0.215 0.941 3.124 0.002
De Raedt et al. (2012) 0.612 0.125 0.016 0.366 0.858 4.883 0.000
Eisendraht et al. (2008) 0.953 0.125 0.016 0.708 1.197 7.638 0.000
Godfrin & van Heeringen (2010) 0.993 0.130 0.017 0.739 1.248 7.643 0.000
Greenberg et al. (2017) 1.431 0.307 0.094 0.829 2.034 4.656 0.000
Hamidian et al. (2013) 1.206 0.213 0.045 0.790 1.623 5.675 0.000
Kenny & Williams (2007) 1.049 0.141 0.020 0.773 1.324 7.456 0.000
Kingston et al. (2007) 1.679 0.460 0.212 0.777 2.581 3.648 0.000
Kuyken et al. (2015) 0.338 0.055 0.003 0.231 0.445 6.195 0.000
Manicavasgar et al. (2011) 0.840 0.200 0.040 0.448 1.233 4.195 0.000
Mann et al. (2016) 0.488 0.181 0.033 0.134 0.843 2.699 0.007
Michalak et al. (2015) 0.750 0.144 0.021 0.468 1.031 5.218 0.000
Van Alderen et al. (2012) 0.527 0.081 0.007 0.368 0.686 6.482 0.000
Verhoeven et al. (2014) 1.035 0.178 0.032 0.686 1.384 5.811 0.000
0.898 0.100 0.010 0.703 1.093 9.017 0.000
-1.00 -0.50 0.00 0.50 1.00
Favors A Favors B
Fig. 6. Forest plot for within-group studies using the BDI.
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therefore, not be included in the analyses. Particular caution is
warranted when interpreting the results from within-studies due to
data dependence (Cuijpers et al., 2017). Heterogeneity was found
to be significant for two of the analyses (between-group studies
using an active treatment control group and the BDI and pre-post
differences on the BDI). The I2 index further indicated that
heterogeneity was low for the two analytical conditions based on
the HDRS (I2 = 0, and I2 = 16.04, respectively), while two of the
conditions based on the BDI showed moderate ranges (I2 = 42.7
and I2 = 64.2, respectively). These values are highly acceptable,
especially when taking into consideration that meta-analyses in
the field of psychology are notorious for having large degrees of
heterogeneity, as proven in a recent study examining rates of I2 in
61 published meta-analyses in Psychological Bulletin between
1990 and 2013 (van Erp, Verhagen, Grasman, & Wagenmakers,
2017). The authors found that over half of the between-study
meta-analyses showed I2> 70. For the final analysis in the present
study, I2 = 86.7 was found for the within–group condition. This
is not uncommon, as higher degrees of heterogeneity are
associated with within-group analyses. The finding may be due to
the less rigid (and less precise) statistical requirements, as no
control groups are implemented in the analysis, thus inherently
leaving room for larger variability between the included studies.
In addition, the high heterogeneity might be due to differences
between studies in the efficacy of MBCT. Future studies should
examine possible additional moderators, e.g., variables related to
the implementation of the treatment. Finally, the present meta-
analysis was restricted to studies that used a version of the BDI or
HDRS as outcome measures. Including studies that used other
instruments could lead to different findings.
In conclusion, the results of the present meta-analysis show that
MBCT is effective in reducing symptoms of current depression
and that study findings are stable over time. However, the
relatively small number and short time range of the studies
included in the analysis require further investigations in the
future.
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